Selected Publications

  1. Adams MP, Rahmim A, Tang J: Improved motor outcome prediction in Parkinson’s disease applying deep learning to DaTscan SPECT images. Computers in Biology and Medicine 2021, 132:104312.
  2. Aertker BM, Kumar A, Cardenas F, Gudenkauf F, Sequeira D, Prossin AR, Srivastava AK, Cox Jr CS, Bedi SS: PET Imaging of Peripheral Benzodiazepine Receptor Standard Uptake Value Increases After Controlled Cortical Impact, a Rodent Model of Traumatic Brain Injury. ASN neuro 2021, 13:17590914211014135.
  3. Ahmed H, Wallimann R, Haider A, Hosseini V, Gruber S, Robledo M, Nguyen TA, Herde AM, Iten I, Keller C: Preclinical development of 18F-OF-NB1 for imaging GluN2B-containing N-methyl-D-aspartate receptors and its utility as a biomarker for amyotrophic lateral sclerosis. Journal of Nuclear Medicine 2021, 62(2):259-265.
  4. Akerele MI, Zein SA, Pandya S, Nikolopoulou A, Gauthier SA, Raj A, Henchcliffe C, Mozley PD, Karakatsanis NA, Gupta A: Population-based input function for TSPO quantification and kinetic modeling with [11 C]-DPA-713. EJNMMI physics 2021, 8(1):1-17.
  5. Albrecht J, Exner S, Grötzinger C, Prasad S, Konietschke F, Beindorff N, Kühl AA, Prasad V, Brenner W, Koziolek EJ: Multimodal Imaging of 2-Cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model. Journal of nuclear medicine 2021, 62(3):393-398.
  6. Alizadeh E, Behlol Ayaz Ahmed K, Raja Solomon V, Gaja V, Bernhard W, Makhlouf A, Gonzalez C, Barreto K, Casaco A, Geyer CR: 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo. Cancers 2021, 13(3):560.
  7. Almeida CGM, Costa-Higuchi K, Piovesan AR, Moro CF, Venturin GT, Greggio S, Costa-Ferro ZS, Salamoni SD, Peigneur S, Tytgat J: Neurotoxic and convulsant effects induced by jack bean ureases on the mammalian nervous system. Toxicology 2021, 454:152737.
  8. Almeida RF, Nonose Y, Ganzella M, Loureiro SO, Rocha A, Machado DG, Bellaver B, Fontella FU, Leffa DT, Pettenuzzo LF: Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse Model. Frontiers in Psychiatry 2021, 12.
  9. An Y-S, Kim S-H, Roh TH, Park SH, Kim T-G, Kim J-H: Correlation Between 18F-FDG Uptake and Immune Cell Infiltration in Metastatic Brain Lesions. Frontiers in Oncology 2021, 11:2451.
  10. An Y-S, Yoon JH, Son SJ, Hong CH, Lee SJ, Yoon J-K: Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated. Scientific reports 2021, 11(1):1-8.
  11. Antons M, Lindner M, Grosch M, Oos R, Palumbo G, Brendel M, Ziegler S, Bartenstein P, Dieterich M, Zwergal A: Structural and Functional Neuroplasticity Following Bilateral Vestibular Loss: A Longitudinal [18F]-UCB-H/[18F]-FDG Dual Tracer Rat Study. 2021.
  12. Attarwala AA, Hardiansyah D, Romanó C, Jiménez-Franco LD, Roscher M, Wängler B, Glatting G: Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99m Tc imaging. Annals of Nuclear Medicine 2021, 35(1):111-120.
  13. Aung W, Tsuji AB, Sugyo A, Fujinaga M, Zhang M-R, Higashi T: Quantitative Radionuclide Imaging Analysis of Enhanced Drug Delivery Induced by Photoimmunotherapy. International Journal of Molecular Sciences 2021, 22(15):8316.
  14. Auvity S, Goutal S, Caillé F, Vodovar D, Pruvost A, Wimberley C, Leroy C, Tonietto M, Bottlaender M, Tournier N: Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo. Neuropsychopharmacology 2021, 46(6):1220-1228.
  15. Avendaño-Estrada A, Rios C, Aguirre-Aranda I, Ávila-Rodríguez MÁ, Manjarrez-Marmolejo J, Franco-Pérez J, Morales J, Olayo R, Méndez-Armenta M, Díaz-Ruíz A: Characterization of metabolic activity induced by kainic acid in adult rat whole brain at the early stage: A 18FDG-PET study. Brain Research 2021, 1769:147621.
  16. Backhaus P, Gierse F, Burg M, Büther F, Asmus I, Dorten P, Cufe J, Roll W, Neri D, Cazzamalli S: Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga] Ga-OncoFAP-DOTAGA. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
  17. Baharikhoob P: Investigating Translocator Protein Binding in Borderline Personality Disorder with Serious Self-Harm Behavior: An [18 F] Feppa Positron Emission Tomography Study. University of Toronto (Canada); 2021.
  18. Bai P, Lan Y, Patnaik D, Wang H, Liu Y, Chen Z, Yuan G, Afshar S, Striar R, Zagaroli JS: Design, Synthesis, and Evaluation of Thienodiazepine Derivatives as Positron Emission Tomography Imaging Probes for Bromodomain and Extra-Terminal Domain Family Proteins. Journal of Medicinal Chemistry 2021, 64(19):14745-14756.
  19. Bai P, Lan Y, Wang H, Liu Y, Striar R, Yuan G, Afshar S, Zagaroli JS, Tocci DR, Langan AG: Synthesis and Characterization of a Positron Emission Tomography Imaging Probe Selectively Targeting the Second Bromodomain of Bromodomain Protein BRD4. Bioconjugate Chemistry 2021.
  20. Bajaj NS, Bhambhvani P: SPECT-derived absolute myocardial perfusion measures: A step in the right direction. In., vol. 28: Springer International Publishing; 2021: 1919-1922.
  21. Bajorat R, Kurth J, Stenzel J, Vollmar B, Krause BJ, Reuter DA, Schuerholz T, Bergt S: Early post-ischemic glucose metabolism is dependent on function of TLR2: a study using [18F] FDG PET-CT in a mouse model of cardiac arrest and cardiopulmonary resuscitation. 2021.
  22. Bakrania P, Hall G, Bouter Y, Bouter C, Beindorff N, Cowan R, Davies S, Price J, Mpamhanga C, Love E: Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease. Molecular psychiatry 2021:1-9.
  23. Balieiro LM, de Oliveira HB, Silva LFT, Bellini MH, Matsuda MMN, de Araujo EB: Study of the automated synthesis of the radiopharmaceutical fluoroestradiol-18F. Brazilian Journal of Radiation Sciences 2021, 9(3).
  24. Baraibar-Argota I: Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade. 2021.
  25. Barret O, Zhang L, Alagille D, Constantinescu CC, Sandiego C, Papin C, Sullivan JM, Morley T, Carroll VM, Seibyl J: Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates. Journal of Nuclear Medicine 2021, 62(9):1307-1313.
  26. Bascuñana P, Wolf BJ, Jahreis I, Brackhan M, García-García L, Ross TL, Bengel FM, Bankstahl M, Bankstahl JP: 99mTc-HMPAO SPECT imaging reveals brain hypoperfusion during status epilepticus. Metabolic brain disease 2021, 36(8):2597-2602.
  27. Bauer M, Bamminger K, Pichler V, Weber M, Binder S, Maier‐Salamon A, Tahir A, Jäger W, Haslacher H, Tournier N: Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology & Therapeutics 2021, 109(3):754-761.
  28. Bauer M, Barna S, Blaickner M, Prosenz K, Bamminger K, Pichler V, Tournier N, Hacker M, Zeitlinger M, Karanikas G: Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [11 C] Metoclopramide. Molecular imaging and biology 2021, 23(2):180-185.
  29. Becker G, Lespine L-F, Bahri MA, Serrano ME, Lemaire C, Luxen A, Tirelli E, Plenevaux A: Exercise against cocaine sensitization in mice: a [18F] fallypride micro-PET study. Brain Communications 2021.
  30. Beindorff N, Schmitz-Peiffer F, Messroghli D, Brenner W, Eary JF: Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae). Scientific Reports 2021, 11(1):1-8.
  31. Bellés L, Dimiziani A, Herrmann FR, Ginovart N: Early environmental enrichment and impoverishment differentially affect addiction-related behavioral traits, cocaine-taking, and dopamine D2/3 receptor signaling in a rat model of vulnerability to drug abuse. Psychopharmacology 2021, 238(12):3543-3557.
  32. Bellés L, Dimiziani A, Tsartsalis S, Millet P, Herrmann FR, Ginovart N: Dopamine D2/3 receptor availabilities and evoked dopamine release in striatum differentially predict impulsivity and novelty preference in Roman high-and low-avoidance rats. International Journal of Neuropsychopharmacology 2021, 24(3):239-251.
  33. Benetos G, Benz DC, Rampidis GP, Giannopoulos AA, von Felten E, Bakula A, Sustar A, Fuchs TA, Pazhenkottil AP, Gebhard C: Coronary artery lumen volume index as a marker of flow-limiting atherosclerosis—validation against 13 N-ammonia positron emission tomography. European Radiology 2021:1-11.
  34. Bengs S, Haider A, Warnock GI, Fiechter M, Pargaetzi Y, Rampidis G, Etter D, Wijnen WJ, Portmann A, Osto E: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(6):1806-1812.
  35. Bengs S, Warnock GI, Portmann A, Mikail N, Rossi A, Ahmed H, Etter D, Gisler L, Jie C, Meisel A: Rest/Stress Myocardial Perfusion Imaging by Positron Emission Tomography with 18F-Flurpiridaz: A Feasibility Study in Mice. bioRxiv 2021.
  36. Bennett KA, Sergeev E, MacSweeney CP, Bakker G, Cooper AE: Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies. Journal of Pharmacology and Experimental Therapeutics 2021, 377(1):157-168.
  37. Benz DC, Ferro P, Safa N, Messerli M, von Felten E, Huang W, Patriki D, Giannopoulos AA, Fuchs TA, Gräni C: Role of quantitative myocardial blood flow and 13N-ammonia washout for viability assessment in ischemic cardiomyopathy. Journal of Nuclear Cardiology 2021, 28(1):263-273.
  38. Benz DC, Kaufmann PA, von Felten E, Benetos G, Rampidis G, Messerli M, Giannopoulos AA, Fuchs TA, Gräni C, Gebhard C: Prognostic value of quantitative metrics from positron emission tomography in ischemic heart failure. Cardiovascular Imaging 2021, 14(2):454-464.
  39. Berberat J, Roelcke U, Remonda L, Schwyzer L: Long-term apparent diffusion coefficient value changes in patients undergoing radiosurgical treatment of meningiomas. Acta Neurochirurgica 2021, 163(1):89-95.
  40. Berger A, Araújo-Filho I, Piffoux M, Nicolás-Boluda A, Grangier A, Boucenna I, Real CC, Marques FLN, de Paula Faria D, do Rego ACM: Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula. Nanoscale 2021, 13(1):218-232.
  41. Bertoglio D, Amhaoul H, Goossens J, Ali I, Jonckers E, Bijnens T, Siano M, Verhaeghe J, Van der Linden A, Staelens S: TSPO PET upregulation predicts epileptic phenotype at disease onset independently from chronic TSPO expression in a rat model of temporal lobe epilepsy. NeuroImage: Clinical 2021:102701.
  42. Bertoglio D, Bard J, Hessmann M, Liu L, Gärtner A, De Lombaerde S, Huscher B, Zajicek F, Miranda A, Peters F: A novel imaging ligand as a biomarker for mutant huntingtin-lowering in Huntington’s disease. BioRxiv 2021.
  43. Bertoglio D, Deleye S, Miranda A, Stroobants S, Staelens S, Verhaeghe J: Estimation of the net influx rate Ki and the cerebral metabolic rate of glucose MRglc using a single static [18F] FDG PET scan in rats. NeuroImage 2021, 233:117961.
  44. Bertoglio D, Verhaeghe J, Miranda A, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M, Bard J, Liu L, Munoz-Sanjuan I: Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington’s Disease mice and post-mortem human HD brain. Journal of Nuclear Medicine 2021.
  45. Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Dominguez C, Munoz-Sanjuan I, Skinbjerg M, Liu L, Staelens S: Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D 1 R Radioligand [11 C] SCH23390 in Healthy and Diseased Mice. Molecular imaging and biology 2021, 23(2):208-219.
  46. Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Mrzljak L, Khetarpal V, Skinbjerg M, Liu L, Dominguez C: Longitudinal preclinical evaluation of the novel radioligand [11C] CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
  47. Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Sauerbeck J, Scheifele M, Prix C, Unterrainer M, Catak C, Pogarell O: Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. NeuroImage: Clinical 2021, 29:102535.
  48. Biechele G, Blume T, Deussing M, Zott B, Shi Y, Xiang X, Franzmeier N, Kleinberger G, Peters F, Ochs K: Pre-therapeutic Microglia Activation and Sex Determine Therapy Effects of Chronic Immunomodulation. bioRxiv 2021.
  49. Biechele G, Monasor LS, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus F-J: Glitter in the Darkness? Non-fibrillar β-amyloid Plaque Components Significantly Impact the β-amyloid PET Signal in Mouse Models of Alzheimer’s Disease. Journal of Nuclear Medicine 2021.
  50. Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S: Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in AppNL-GF mice. NeuroImage 2021, 230:117707.
  51. Bindini E, Ramirez MdlA, Rios X, Cossío U, Simó C, Gomez‐Vallejo V, Soler‐Illia G, Llop J, Moya SE: In Vivo Tracking of the Degradation of Mesoporous Silica through 89Zr Radio‐Labeled Core–Shell Nanoparticles. Small 2021:2101519.
  52. Bolcaen J, Descamps B, Deblaere K, De Vos F, Boterberg T, Hallaert G, Van den Broecke C, Vanhove C, Goethals I: Assessment of the effect of therapy in a rat model of glioblastoma using [18F] FDG and [18F] FCho PET compared to contrast-enhanced MRI. Plos one 2021, 16(3):e0248193.
  53. Bonaventura J, Lam S, Carlton M, Boehm MA, Gomez JL, Solís O, Sánchez-Soto M, Morris PJ, Fredriksson I, Thomas CJ: Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Molecular Psychiatry 2021:1-19.
  54. Borelli WV, Leal-Conceição E, Andrade MA, Esper NB, Feltes PK, Soder RB, Matushita CS, Hartmann LM, Radaelli G, Schilling LP: Increased Glucose Activity in Subgenual Anterior Cingulate and Hippocampus of High Performing Older Adults, Despite Amyloid Burden. Journal of Alzheimer’s Disease 2021(Preprint):1-10.
  55. Bossart M, Wagner M, Elvert R, Evers A, Hübschle T, Kloeckener T, Lorenz K, Moessinger C, Eriksson O, Velikyan I: Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. Cell Metabolism 2021.
  56. Bouter C, Irwin C, Franke TN, Beindorff N, Bouter Y: Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations. Frontiers in Medicine 2021, 8.
  57. Bratanovic IJ, Zhang C, Zhang Z, Kuo H-T, Colpo N, Zeisler J, Merkens H, Uribe C, Lin K-S, Bénard F: A Novel Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor Positive Prostate Cancer. Journal of Nuclear Medicine 2021.
  58. Breuil L, Marie S, Goutal S, Auvity S, Truillet C, Saba W, Langer O, Caillé F, Tournier N: Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice? Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211045444.
  59. Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S: Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms?–A preclinical assessment in vitro and in vivo. Neoplasia 2021, 23(1):80-98.
  60. Brodsky L, Chesnais H, Piri R, Høilund-Carlsen PF: Association of baseline subject characteristics with changes 18 in coronary calcification assessed by F-sodium fluoride PET/CT. 2021.
  61. Broqueza J: Developing radioimmunotherapy for osteosarcoma using comparative oncology. University of Saskatchewan; 2021.
  62. Broqueza J, Prabaharan CB, Andrahennadi S, Allen KJ, Dickinson R, MacDonald-Dickinson V, Dadachova E, Uppalapati M: Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma. Cancers 2021, 13(9):2208.
  63. Brosch-Lenz J: Towards personalized internal radionuclide therapies with 90Y SIRT and 177Lu-PSMA: an investigation of 3D image based dosimetry. lmu; 2021.
  64. Brosch-Lenz J, Uribe C, Gosewisch A, Kaiser L, Todica A, Ilhan H, Gildehaus FJ, Bartenstein P, Rahmim A, Celler A: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. EJNMMI physics 2021, 8(1):1-17.
  65. Brumberg J, Kuzkina A, Lapa C, Mammadova S, Buck A, Volkmann J, Sommer C, Isaias IU, Doppler K: Dermal and cardiac autonomic fiber involvement in Parkinson’s disease and multiple system atrophy. Neurobiology of Disease 2021, 153:105332.
  66. Bu L-L, Liu Y-Q, Shen Y, Fan Y, Yu W-B, Jiang D-L, Tang Y-L, Yang Y-J, Wu P, Zuo C-T: Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy. Neurotherapeutics 2021:1-17.
  67. Bucci M, Savitcheva I, Farrar G, Salvadó G, Collij L, Doré V, Gispert JD, Gunn R, Hanseeuw B, Hansson O: A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F] flutemetamol amyloid PET images. European journal of nuclear medicine and molecular imaging 2021, 48(7):2183-2199.
  68. Bunai T, Hirosawa T, Kikuchi M, Fukai M, Yokokura M, Ito S, Takata Y, Terada T, Ouchi Y: tDCS-induced modulation of GABA concentration and dopamine release in the human brain: A combination study of magnetic resonance spectroscopy and positron emission tomography. Brain Stimulation 2021, 14(1):154-160.
  69. Burvenich IJG, Goh YW, Guo N, Gan HK, Rigopoulos A, Cao D, Liu Z, Ackermann U, Wichmann CW, McDonald AF: Radiolabelling and preclinical characterization of 89 Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European journal of nuclear medicine and molecular imaging 2021:1-14.
  70. Busatto Filho G, Duran FLdS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGdF, da Costa NA, Porto FHdG, Carvalho CL: Hippocampal subregional volume changes in elders classified using positron emission tomography‐based Alzheimer’s biomarkers of β‐amyloid deposition and neurodegeneration. Journal of Neuroscience Research 2021, 99(2):481-501.
  71. Calsbeek JJ, González EA, Boosalis CA, Zolkowska D, Bruun DA, Rowland DJ, Saito NH, Harvey DJ, Chaudhari AJ, Rogawski MA: Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus. Neurotoxicology 2021, 87:43-50.
  72. Caminiti SP, Sala A, Presotto L, Chincarini A, Sestini S, Perani D, Schillaci O, Berti V, Calcagni ML, Cistaro A: Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps. European journal of nuclear medicine and molecular imaging 2021:1-14.
  73. Campanholo K, Pitombeira M, Rimkus C, Mendes M, Apóstolos-Pereira S, Busatto Filho G, Callegaro D, Buchpiguel C, Duran F, Faria DDP: Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study. Multiple Sclerosis and Related Disorders 2021:103331.
  74. Campoy A-DT, Liang C, Ladwa RM, Patel KK, Patel IH, Mukherjee J: [18F] Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease. Molecules 2021, 26(23):7360.
  75. Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE: Dosimetry for radiopharmaceutical therapy: current practices and commercial resources. Journal of Nuclear Medicine 2021, 62(Supplement 3):3S-11S.
  76. Castro-Balado A, Mondelo-García C, Barbosa-Pereira L, Varela-Rey I, Novo-Veleiro I, Vázquez-Agra N, Antúnez-López JR, Bandín-Vilar EJ, Sendón-García R, Busto-Iglesias M: Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection. Pharmaceutics 2021, 13(3):342.
  77. Cavalcante MF, Adorne MD, Turato WM, Kemmerer M, Uchiyama MK, Asbahr ACC, Alves AdCS, Farsky SHP, Drewes C, Spatti MC: scFv-Anti-LDL (-)-Metal-Complex Multi-Wall Functionalized-Nanocapsules as a Promising Tool for the Prevention of Atherosclerosis Progression. Frontiers in medicine 2021, 8:446.
  78. Cawthorne C, Maguire P, Mercier J, Sciberras D, Serdons K, Bormans G, de Hoon J, Van Laere K, Koole M: Human biodistribution and dosimetry of [11 C]-UCB-J, a PET radiotracer for imaging synaptic density. EJNMMI physics 2021, 8(1):1-11.
  79. Cecchini MA, Yassuda MS, Squarzoni P, Coutinho AM, de Paula Faria D, de Souza Duran FL, da Costa NA, de Gobbi Porto FH, Nitrini R, Forlenza OV: Deficits in short-term memory binding are detectable in individuals with brain amyloid deposition in the absence of overt neurodegeneration in the Alzheimer’s disease continuum. Brain and Cognition 2021, 152:105749.
  80. Ceccon G, Lohmann P, Werner J-M, Tscherpel C, Dunkl V, Stoffels G, Rosen J, Rapp M, Sabel M, Herrlinger U: Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy. Journal of Nuclear Medicine 2021, 62(7):918-925.
  81. Cerri G, Tognon M, Avesani S, Oxtoby N, Altmann A, Giugno R: Multi view based imaging genetics analysis on Parkinson disease. bioRxiv 2021.
  82. Ceyzériat K, Gloria Y, Tsartsalis S, Fossey C, Cailly T, Fabis F, Millet P, Tournier BB: Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer’s disease. Brain Communications 2021, 3(2):fcab029.
  83. Chan CY, Hopkins SL, Guibbal F, Pacelli A, Torres JB, Mosley M, Lau D, Isenegger P, Chen Z, Wilson TC: PET Imaging Using [18F] olaparib in Mouse Models of Malignant Glioma: Considerations for Molecular Imaging and Radionuclide Therapy Targeting PARP. 2021.
  84. Chan S-C, Ng S-H, Yeh C-H, Chang K-P: Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and 18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure. Tzu-Chi Medical Journal 2021, 33(1):61.
  85. Chan S-C, Yeh C-H, Chang JT-C, Chang K-P, Wang J-H, Ng S-H: Combing MRI Perfusion and 18F-FDG PET/CT Metabolic Biomarkers Helps Predict Survival in Advanced Nasopharyngeal Carcinoma: A Prospective Multimodal Imaging Study. Cancers 2021, 13(7):1550.
  86. Chaney AM, Lopez-Picon FR, Serrière S, Wang R, Bochicchio D, Webb SD, Vandesquille M, Harte MK, Georgiadou C, Lawrence C: Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study. Theranostics 2021, 11(14):6644.
  87. Chang C-W, Chiu C-H, Lin M-H, Wu H-M, Yu T-H, Wang P-Y, Kuo Y-Y, Huang Y-Y, Shiue C-Y, Huang W-S: GMP-compliant fully automated radiosynthesis of [18 F] FEPPA for PET/MRI imaging of regional brain TSPO expression. EJNMMI research 2021, 11(1):1-15.
  88. Chanisa C, Monchaya N, Anchisa K, Chetsadaporn P, Attapon J: Analysis of amyloid and tau deposition in Alzheimer’s disease using 11C-Pittsburgh compound B and 18F-THK 5351 positron emission tomography imaging. World Journal of Nuclear Medicine 2021, 20(1):61.
  89. Charifi W, Fauveau V, Francese L, Grosfeld A, Le Gall M, Ourabah S, Ellero-Simatos S, Viel T, Cauzac M, Gueddouri D: Loss of intestinal ChREBP impairs absorption of dietary sugars and prevents glycemic excursion curves. bioRxiv 2021.
  90. Chen TB, Lin K-J, Lin S-Y, Lee Y-J, Lin Y-C, Wang C-J, Chen J-P, Wang P-N: Prediction of cerebral amyloid pathology based on plasma amyloid and tau related markers. Frontiers in Neurology 2021:1765.
  91. Chen X, Zhang Q, Zhang Y, Fang J, Jiang D, Mou Z, Liu H, Su R, Wang C, He F: 18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson’s disease. European Journal of Medicinal Chemistry 2021, 214:113245.
  92. Chen Y, Li L, Yu X, Wang J, Wang Y, Huang G, Liu J: Is Dynamic Total-body PET Imaging Feasible in the Clinical Daily Practice? 2021.
  93. Chen Y-A, Lu C-H, Ke C-C, Chiu S-J, Chang C-W, Yang B-H, Gelovani JG, Liu R-S: Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease. International journal of molecular sciences 2021, 22(16):8633.
  94. Chen Y-A, Lu C-H, Ke C-C, Chiu S-J, Jeng F-S, Chang C-W, Yang B-H, Liu R-S: Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits. Biomedicines 2021, 9(6):594.
  95. Chen Y-H, Chu S-C, Wang L-Y, Wang T-F, Lue K-H, Lin C-B, Chang B-S, Liu D-W, Liu S-H, Chan S-C: Prognostic Value of Combing Primary Tumor and Nodal Glycolytic–Volumetric Parameters of 18F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis. Diagnostics 2021, 11(6):1065.
  96. Chen Y-J, Lin C-W, Peng Y-J, Huang C-W, Chien Y-S, Huang T-H, Liao P-X, Yang W-Y, Wang M-H, Mersmann HJ: Overexpression of Adiponectin Receptor 1 Inhibits Brown and Beige Adipose Tissue Activity in Mice. International journal of molecular sciences 2021, 22(2):906.
  97. Cherix A, Donati G, Lizarbe B, Lanz B, Poitry-Yamate C, Lei H, Gruetter R: Excitatory/inhibitory neuronal metabolic balance in mouse hippocampus upon infusion of [U-13C6] glucose. Journal of Cerebral Blood Flow & Metabolism 2021, 41(2):282-297.
  98. Cheung P, Zhang B, Puuvuori E, Estrada S, Amin MA, Ye S, Korsgren O, Odell LR, Eriksson J, Eriksson O: PET Imaging of GPR44 by Antagonist [11C] MK-7246 in Pigs. Biomedicines 2021, 9(4):434.
  99. Chin W-C, Liu F-Y, Huang Y-S, Hsiao I-T, Wang C-H, Chen Y-C: Different positron emission tomography findings in schizophrenia and narcolepsy type 1 in adolescents and young adults: a preliminary study. Journal of Clinical Sleep Medicine 2021, 17(4):739-748.
  100. Choi K-M, Kim JH, Kong X, Isik M, Zhang J, Lim H-W, Yoon JC: Defective brown adipose tissue thermogenesis and impaired glucose metabolism in mice lacking Letmd1. Cell reports 2021, 37(11):110104.
  101. Chotipanich C, Jantarato A, Kunawudhi A, Kongthai S, Promteangtrong C: 11C-Pittsburgh compound B and 18F-THK 5351 positron emission tomography brain imaging in cognitively normal individuals. World Journal of Nuclear Medicine 2021, 20(2):133.
  102. Chotiwan N, Willekens SM, Schexnaydre E, Hahn M, Morini F, Zhang J, Nilsson E, Carlson L-A, Ahlgren U, Marcellino D: Whole-brain fluorescence-MRI coregistration for precise anatomical mapping of virus infection. bioRxiv 2021.
  103. Chun K, Kong E, Cho I: Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders. Medicine 2021, 100(34).
  104. Chung S-Y, Hung Y-P, Pan Y-R, Chang Y-C, Wu C-E, Hsu DS-S, Chang PM-H, Lu M-L, Huang C-YF, Su Y: Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the jak2/stat1/3/aldh1a3 Pathway. 2021.
  105. Chung Y-H, Tsai C-K, Yu C-F, Wang W-L, Yang C-L, Hong J-H, Yen T-C, Chen F-H, Lin G: Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from 18F-FDG PET Imaging and Tissue NMR Metabolomics in a Mouse Model for Hepatocellular Carcinoma. Molecules 2021, 26(9):2573.
  106. Clemente GS, Antunes IF, Kurhade S, van den Berg M, Sijbesma JW, van Waarde A, Buijsmam RC, Willemsen-Seegers N, Gosens R, Meurs H: Mapping arginase expression with 18F-fluorinated late-generation arginase inhibitors derived from quaternary α-amino acids. Journal of Nuclear Medicine 2021.
  107. Clemente GS, Antunes IF, Sijbesma JrW, van Waarde A, Lammertsma AA, Dömling A, Elsinga PH: [18F] Atorvastatin Pharmacokinetics and Biodistribution in Healthy Female and Male Rats. Molecular pharmaceutics 2021, 18(9):3378-3386.
  108. Coda A, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G: In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18 F] DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. European journal of nuclear medicine and molecular imaging 2021, 48(1):40-52.
  109. Connell NJ, Doligkeit D, Andriessen C, Kornips-Moonen E, Bruls YM, Schrauwen-Hinderling VB, van de Weijer T, van Marken-Lichtenbelt WD, Havekes B, Kazak L: No evidence for brown adipose tissue activation after creatine supplementation in adult vegetarians. Nature Metabolism 2021, 3(1):107-117.
  110. Corral A, Olmo A, Risco R: Use of X-Ray Computed Tomography for Monitoring Tissue Permeation Processes. In: Cryopreservation and Freeze-Drying Protocols. edn.: Humana, New York, NY; 2021: 317-330.
  111. Corroyer-Dulmont A, Valable S, Fantin J, Chatre L, Toutain J, Teulier S, Bazille C, Letissier E, Levallet J, Divoux D: Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy. Scientific reports 2021, 11(1):1-15.
  112. Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Azad BB, Holt DP, Fan H, Lesniak WG, Minn I: First-in-human neuroimaging of soluble epoxide hydrolase using [18 F] FNDP PET. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-7.
  113. Crimì F, Stramare R, Spolverato G, Aldegheri V, Barison A, D’Alimonte L, Bao Q, Spimpolo A, Albertoni L, Cecchin D: T2-weighted, apparent diffusion coefficient and 18 F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy. Techniques in Coloproctology 2021, 25(5):569-577.
  114. Cui Y: [18F] DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus. 2021.
  115. d’Abadie P, Walrand S, Hesse M, Annet L, Borbath I, Van den Eynde M, Lhommel R, Jamar F: Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nuclear Medicine Communications 2021, 42(7):747-754.
  116. D’Amore F, Grinberg F, Mauler J, Galldiks N, Blazhenets G, Farrher E, Filss C, Stoffels G, Mottaghy FM, Lohmann P: Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes. Neuro-oncology advances 2021, 3(1):vdab044.
  117. D’Amore F, Grinberg F, Mauler J, Galldiks N, Blazhenets G, Farrher E, Filss C, Stoffels G, Mottaghy FM, Lohmann P: Neuro-Oncology Advances. 2021.
  118. Damian A, Pineyro MM, Quagliata A, Risso M, Montiglia P, Lima R, Alonso O: 18F-fallypride and 11C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series. World Journal of Nuclear Medicine 2021, 20(3):286.
  119. Darr C, Costa PF, Kesch C, Krafft U, Püllen L, Harke NN, Hess J, Szarvas T, Haubold J, Reis H: Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls. Translational Andrology and Urology 2021, 10(10):3972.
  120. de Laat B, Kling YE, Schroyen G, Ooms M, Hooker JM, Bormans G, Van Laere K, Ceccarini J: Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F] JNJ42259152 PET study in rats. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
  121. de Vor L, van Dijk B, van Kessel KP, Kavanaugh JS, de Haas CJ, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM: Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro biofilm and in vivo implant infections. bioRxiv 2021.
  122. Delage C, Vignal N, Guerin C, Taib T, Barboteau C, Mamma C, Khacef K, Margaill I, Sarda-Mantel L, Rizzo-Padoin N: From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury. Scientific Reports 2021, 11(1):1-11.
  123. Delage JA, Gnesin S, Prior JO, Barbet J, Le Saëc P, Marionneau-Lambot S, Gouard S, Chérel M, Bourgeois M, Schaefer N: Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety. Cancers 2021, 13(23):5936.
  124. DEPIERREUX F: Multimodal Imaging In Parkinson’s Disease: Exploring Iron–, Neuromelanin-Sensitive MRI And FDOPA PET Relationships. Université de Liège,​ Liège,​​ Belgique; 2021.
  125. Depierreux F, Parmentier E, Mackels L, Baquero K, Degueldre C, Balteau E, Salmon E, Phillips C, Bahri MA, Maquet P: Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. npj Parkinson’s Disease 2021, 7(1):1-10.
  126. Dewulf J, Vangestel C, Verhoeven Y, De Waele J, Zwaenepoel K, van Dam PA, Elvas F, Van den Wyngaert T: Immuno-PET Molecular Imaging of RANKL in Cancer. Cancers 2021, 13(9):2166.
  127. Deyev SM, Xu T, Liu Y, Schulga A, Konovalova E, Garousi J, Rinne SS, Larkina M, Ding H, Gräslund T: Influence of the position and composition of radiometals and radioiodine labels on imaging of Epcam expression in prostate cancer model using the DARPin Ec1. Cancers 2021, 13(14):3589.
  128. Di Ciano P, de Wit H, Mansouri E, Houle S, Boileau I, Le Foll B: The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence. Scientific Reports 2021, 11(1):1-7.
  129. Dias AH, Pedersen MF, Danielsen H, Munk OL, Gormsen LC: Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body 18 F-FDG PET/CT scans. European journal of nuclear medicine and molecular imaging 2021, 48(3):837-850.
  130. Diaz AMA, Drumeva GO, Laporte P, Martinez LMA, Petrenyov DR, Carrier J-F, DaSilva JN: Evaluation of the high affinity [18F] fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors. Nuclear Medicine and Biology 2021, 96:41-49.
  131. Diggelmann F, Bengs S, Haider A, Epprecht G, Beeler AL, Etter D, Wijnen WJ, Portmann A, Warnock GI, Treyer V: Potential Impact of Statins on Neuronal Stress Responses in Patients at Risk for Cardiovascular Disease. Journal of Personalized Medicine 2021, 11(4):261.
  132. Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Kinetic modeling and parametric imaging with dynamic PET for oncological applications: General considerations, current clinical applications, and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48:21-39.
  133. Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C: Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use. In: Seminars in Nuclear Medicine: 2021: Elsevier; 2021.
  134. Ding J, Tong A, Zhang Y, Wen J, Zhang H, Hacker M, Huo L, Li X: Functional characterization of adrenocortical masses in nononcological patients using [68Ga]-pentixafor. Journal of Nuclear Medicine 2021.
  135. do Carmo Barbosa JV, Gontijo RMG, de Albuquerque Souza GC, Mendes BM, da Silva JB, Mamede M, Ferreira AV: Influence of image reconstruction protocols on the image quality of a small animal PET scanner using 18F and 11C. Brazilian Journal of Radiation Sciences 2021, 9(3).
  136. Dockx R, Baeken C, Vermeire S, Waelbers T, Xu Y, Dobbeleir A, Audenaert K, Peremans K: Brain SPECT in the Behaviourally Disordered Dog. In: PET and SPECT in Psychiatry. edn.: Springer, Cham; 2021: 817-839.
  137. Dockx Y, Vangestel C, Van den Wyngaert T, Huizing M, De Bruycker S, Pauwels P, Staelens S, Stroobants S: Early Changes in [18F] FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts. Molecular imaging 2021, 2021.
  138. Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM: Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig. European Neuropsychopharmacology 2021, 42:1-11.
  139. Dorraji ES, Oteiza A, Kuttner S, Martin-Armas M, Kanapathippillai P, Garbarino S, Kalda G, Scussolini M, Piana M, Fenton KA: Positron emission tomography and single photon emission computed tomography imaging of tertiary lymphoid structures during the development of lupus nephritis. International Journal of Immunopathology and Pharmacology 2021, 35:20587384211033683.
  140. Duong MT, Chen YJ, Doot RK, Young AJ, Lee H, Cai J, Pilania A, Wolk DA, Nasrallah IM: Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology. Nuclear Medicine Communications 2021, 42(11):1261-1269.
  141. Dupont A-C, Serrière S, Barantin L, Vercouillie J, Tauber C, Gissot V, Bodard S, Chicheri G, Chalon S, Bonnet-Brilhault PF: Study of influence of the glutamatergic concentration of [18 F] FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers. Translational Psychiatry 2021, 11(1):1-10.
  142. Durán‐Carabali LE, Odorcyk FK, Greggio S, Venturin GT, Sanches EF, Schu GG, Carvalho AS, Pedroso TA, de Sá Couto‐Pereira N, Da Costa JC: Pre‐and early postnatal enriched environmental experiences prevent neonatal hypoxia‐ischemia late neurodegeneration via metabolic and neuroplastic mechanisms. Journal of Neurochemistry 2021, 157(6):1911-1929.
  143. Durand-Panteix S, Monteil J, Sage M, Garot A, Clavel M, Saidi A, Torgue J, Cogne M, Quelven I: Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma. British journal of cancer 2021, 125(12):1657-1665.
  144. El Biali M, Karch R, Philippe C, Haslacher H, Tournier N, Hacker M, Zeitlinger M, Schmidl D, Langer O, Bauer M: ABCB1 and ABCG2 together limit the distribution of ABCB1/ABCG2 substrates to the human retina and the ABCG2 single nucleotide polymorphism Q141K (c. 421C> A) may lead to increased drug exposure. Frontiers in pharmacology 2021, 12.
  145. Eriksson O, Velikyan I, Haack T, Bossart M, Evers A, Lorenz K, Laitinen I, Larsen PJ, Plettenburg O, Johansson L: Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography. Diabetes 2021, 70(4):842-853.
  146. Eriksson O, Velikyan I, Haack T, Bossart M, Laitinen I, Larsen PJ, Berglund JE, Antoni G, Johansson L, Pierrou S: Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes. Journal of Nuclear Medicine 2021.
  147. Espes D, Carlsson P-O, Selvaraju RK, Rosestedt M, Cheung P, Ahlström H, Korsgren O, Eriksson O: Longitudinal assessment of 11C-5-Hydroxytryptophan uptake in pancreas after debut of Type 1 Diabetes. Diabetes 2021, 70(4):966-975.
  148. Eu WZ, Chen Y-J, Chen W-T, Wu K-Y, Tsai C-Y, Cheng S-J, Carter RN, Huang G-J: The effect of nerve growth factor on supporting spatial memory depends upon hippocampal cholinergic innervation. Translational psychiatry 2021, 11(1):1-13.
  149. Ezura M, Kikuchi A, Okamura N, Ishiki A, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T: 18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies. Frontiers in Aging Neuroscience 2021, 13.
  150. Fairley LH, Sahara N, Aoki I, Ji B, Suhara T, Higuchi M, Barron AM: Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy. Journal of Neuroinflammation 2021, 18(1):1-13.
  151. Fan X, He S, Song H, Yin W, Zhang J, Peng Z, Yang K, Zhai X, Zhao L, Gong H: Human endometrium-derived stem cell improves cardiac function after myocardial ischemic injury by enhancing angiogenesis and myocardial metabolism. Stem cell research & therapy 2021, 12(1):1-16.
  152. Farn S-S, Chang K-W, Lin W-C, Yu H-M, Lin K-L, Tseng Y-C, Chang Y, Yu C-S, Lin W-J: Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [68Ga] IPCAT-NOTA as an Imaging Agent for Dopamine Transporter. Drug Design, Development and Therapy 2021, 15:2577.
  153. Feiner IV, Pulagam KR, Uribe KB, Passannante R, Simó C, Zamacola K, Gómez-Vallejo V, Herrero-Álvarez N, Cossío U, Baz Z: Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy. Journal of Materials Chemistry B 2021, 9(2):410-420.
  154. Félix‐Soriano E, Sáinz N, Gil‐Iturbe E, Collantes M, Fernández‐Galilea M, Castilla‐Madrigal R, Ly L, Dalli J, Moreno‐Aliaga MJ: Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice. The FASEB Journal 2021, 35(6):e21592.
  155. Ferraro DA, Laudicella R, Zeimpekis K, Mebert I, Müller J, Maurer A, Grünig H, Donati O, Sapienza MT, Rueschoff JH: Hot needles can confirm accurate lesion sampling intraoperatively using [18F] PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer. European journal of nuclear medicine and molecular imaging 2021:1-10.
  156. Ferrer-Ugalde A, Sandoval S, Pulagam KR, Muñoz-Juan A, Laromaine A, Llop J, Tobias G, Núñez R: Radiolabeled Cobaltabis (dicarbollide) Anion–Graphene Oxide Nanocomposites for In Vivo Bioimaging and Boron Delivery. ACS Applied Nano Materials 2021, 4(2):1613-1625.
  157. Ferté L, Marino A, Battault S, Bultot L, Van Steenbergen A, Bol A, Cumps J, Ginion A, Koepsell H, Dumoutier L: New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans. American Journal of Physiology-Heart and Circulatory Physiology 2021, 320(2):H838-H853.
  158. Fiedorowicz K, Wargocka-Matuszewska W, Ambrożkiewicz KA, Rugowska A, Cheda Ł, Fiedorowicz M, Zimna A, Drabik M, Borkowski S, Świątkiewicz M: Molecular Imaging of Human Skeletal Myoblasts (huSKM) in Mouse Post-Infarction Myocardium. International journal of molecular sciences 2021, 22(19):10885.
  159. Filip T, Mairinger S, Neddens J, Sauberer M, Flunkert S, Stanek J, Wanek T, Okamura N, Langer O, Hutter-Paier B: Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling. Alzheimer’s research & therapy 2021, 13(1):1-13.
  160. Fleury Curado T, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG: Designer receptors exclusively activated by designer drugs approach to treatment of sleep-disordered breathing. American journal of respiratory and critical care medicine 2021, 203(1):102-110.
  161. Florea A, Sigl JP, Morgenroth A, Vogg A, Sahnoun S, Winz OH, Bucerius J, Schurgers LJ, Mottaghy FM: Sodium [18F] Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment. Cells 2021, 10(2):275.
  162. Fois GR, Valla C, Jouberton E, Sas N, Billoux T, Auzeloux P, Cachin F, Miot‐Noirault E, Maigne L: Internal dosimetry of [99mTc] NTP15‐5 radiotracer for cartilage imaging in preclinical and clinical models using the GATE Monte Carlo platform. Medical Physics 2021, 48(1):477-487.
  163. Fraz MSA, Moe N, Revheim M-E, Stavrinou ML, Durheim MT, Nordøy I, Macpherson ME, Aukrust P, Jørgensen SF, Aaløkken TM: Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency—Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease. Frontiers in immunology 2021:3606.
  164. Fung LK, Flores RE, Gu M, Sun KL, James D, Schuck RK, Jo B, Park JH, Lee BC, Jung JH: Thalamic and prefrontal GABA concentrations but not GABAA receptor densities are altered in high-functioning adults with autism spectrum disorder. Molecular psychiatry 2021, 26(5):1634-1646.
  165. Gade S, Hjørnevik T, Park JH, Shen B, Gu M, Tseng J, Barbosa D, Leuze C, Pitteri S, Jung J: The first awake simultaneous PET-MR study of an adult with fragile X syndrome: A case report. 2021.
  166. Gao Y, Li Z, Song C, Li L, Li M, Schmall J, Liu H, Yuan J, Wang Z, Zeng T: Automatic rat brain image segmentation using triple cascaded convolutional neural networks in a clinical PET/MR. Physics in Medicine & Biology 2021, 66(4):04NT01.
  167. Gao Y, Wu S, Pan J, Zhang K, Li X, Xu Y, Jin C, He X, Shi J, Ma L: CRISPR/Cas9-edited triple-fusion reporter gene imaging of dynamics and function of transplanted human urinary-induced pluripotent stem cell-derived cardiomyocytes. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(3):708-720.
  168. García-Varela L, García DV, Aguiar P, Kakiuchi T, Ohba H, Harada N, Nishiyama S, Tago T, Elsinga PH, Tsukada H: Head-to-head comparison of (R)-[11C] verapamil and [18F] MC225 in non-human primates, tracers for measuring P-glycoprotein function. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
  169. García-Varela L, Rodríguez-Pérez M, Custodia A, Moraga-Amaro R, Colabufo NA, Aguiar P, Sobrino T, Dierckx RA, van Waarde A, Elsinga PH: In Vivo Induction of P-Glycoprotein Function can be Measured with [18F] MC225 and PET. Molecular pharmaceutics 2021.
  170. Garnier‐Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B, Gonneaud J, De Flores R, de la Sayette V, Vivien D: White matter hyperintensity topography in Alzheimer’s disease and links to cognition. Alzheimer’s & Dementia 2021.
  171. Garrido V, Piñero‐Lambea C, Rodriguez‐Arce I, Paetzold B, Ferrar T, Weber M, Garcia‐Ramallo E, Gallo C, Collantes M, Peñuelas I: Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo. Molecular systems biology 2021, 17(10):e10145.
  172. Gasiorek A, Dobosz E, Potempa B, Ciaston I, Wilamowski M, Oruba Z, Lamont RJ, Jura J, Potempa J, Koziel J: Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts. Mbio 2021, 12(3):e00502-00521.
  173. Gelston D, Brosler SC, Vazquez J, Sorci O, Griffith AH, Chatterjee S, Buchner A, Høilund-Carlsen PF, Alavi A, Rajapakse CS: Utility of FDG PET/CT in assessing bowel inflammation. American Journal of Nuclear Medicine and Molecular Imaging 2021, 11(4):271.
  174. Geraldo LH, Xu Y, Jacob L, Pibouin-Fragner L, Rao R, Maissa N, Verreault M, Lemaire N, Knosp C, Lesaffre C: SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia. bioRxiv 2021.
  175. Ghodoosi EK: Improving Quantitative Imaging Accuracy for Dosimetry of Lutetium-177-PSMA Imaging &Therapy. Technische Universität München; 2021.
  176. Ghosh KK, Padmanabhan P, Yang C-T, Wang Z, Palanivel M, Ng KC, Lu J, Carlstedt-Duke J, Halldin C, Gulyás B: An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [11C] PBR28 and [18F] flumazenil PET Imaging. International Journal of Molecular Sciences 2021, 22(2):951.
  177. Giglio J, Fernandez S, Martinez A, Zeni M, Reyes L, Rey A, Cerecetto H: Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer’s Disease: 11C-Synthesis and In Vivo Proof of Concept. Journal of Medicinal Chemistry 2021.
  178. Girard A, Francois M, Chaboub N, Le Reste P-J, Devillers A, Saint-Jalmes H, Le Jeune F, Palard-Novello X: Impact of point-spread function reconstruction on dynamic and static F-18-DOPA PET/CT quantitative parameters in glioma. Quantitative Imaging in Medicine and Surgery 2021.
  179. Girard A, Le Reste P-J, Metais A, Chaboub N, Devillers A, Saint-Jalmes H, Jeune FL, Palard-Novello X: Additive Value of Dynamic FDOPA PET/CT for Glioma Grading. Frontiers in Medicine 2021, 8:1106.
  180. Glorie D, Verhaeghe J, Miranda A, De Lombaerde S, Stroobants S, Staelens S: Quantification of metabotropic glutamate receptor 5 availability with both [11C] ABP688 and [18F] FPEB positron emission tomography in the Sapap3 knockout mouse model for obsessive compulsive-like behavior. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2021.
  181. Golan S, Aviv T, Groshar D, Yakimov M, Zohar Y, Prokocimer Y, Nadu A, Baniel J, Domachevsky L, Bernstine H: Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study. Journal of Nuclear Medicine 2021, 62(6):773-778.
  182. Gomez JL, Bonaventura J, Keighron J, Wright KM, Marable DL, Rodriguez LA, Lam S, Carlton ML, Ellis RJ, Jordan CJ: Synaptic Zn2+ potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior. Translational psychiatry 2021, 11(1):1-15.
  183. Gonzalez-Galofre ZN, Alcaide-Corral CJ, Tavares AA: Effects of administration route on uptake kinetics of 18 F-sodium fluoride positron emission tomography in mice. Scientific reports 2021, 11(1):1-8.
  184. González-Mancebo D, Becerro AI, Calderón-Olvera RM, Cantelar E, Corral A, Balcerzyk M, Jesús M, Ocaña M: Neodymium doped lanthanide fluoride nanoparticles as contrast agents for luminescent bioimaging and X-ray computed tomography. Boletín de la Sociedad Española de Cerámica y Vidrio 2021.
  185. Gordon O, Lee DE, Liu B, Langevin B, Ordonez AA, Dikeman DA, Shafiq B, Thompson JM, Sponseller PD, Flavahan K: Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant–associated infections. Science translational medicine 2021, 13(622):eabl6851.
  186. Goutal S, Guillermier M, Becker G, Gaudin M, Bramoullé Y, Luxen A, Lemaire C, Plenevaux A, Salmon E, Hantraye P: The pharmacokinetics of [18 F] UCB-H revisited in the healthy non-human primate brain. EJNMMI research 2021, 11(1):1-9.
  187. Grachev ID, Meyer PM, Becker GA, Bronzel M, Marsteller D, Pastino G, Voges O, Rabinovich L, Knebel H, Zientek F: Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18 F] fluspidine and [18 F] fallypride PET study. European journal of nuclear medicine and molecular imaging 2021, 48(4):1103-1115.
  188. Grecco GG, Mork BE, Huang J-Y, Metzger CE, Haggerty DL, Reeves KC, Gao Y, Hoffman H, Katner SN, Masters AR: Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry. Elife 2021, 10:e66230.
  189. Grosch M: Metabolic brain connectivity after acute unilateral vestibulopathy: Longitudinal analysis and single subject classification in the rat. lmu; 2021.
  190. Grosch M, Beyer L, Lindner M, Kaiser L, Ahmadi S-A, Stockbauer A, Bartenstein P, Dieterich M, Brendel M, Zwergal A: Metabolic connectivity-based single subject classification by multi-regional linear approximation in the rat. NeuroImage 2021, 235:118007.
  191. Grosch M, Lindner M, Bartenstein P, Brandt T, Dieterich M, Ziegler S, Zwergal A: Dynamic whole-brain metabolic connectivity during vestibular compensation in the rat. NeuroImage 2021, 226:117588.
  192. Gullberg GT, Shrestha UM, Veress AI, Segars WP, Liu J, Ordovas K, Seo Y: Novel Methodology for Measuring Regional Myocardial Efficiency. IEEE Transactions on Medical Imaging 2021, 40(6):1711-1725.
  193. Gündel D, Sadeghzadeh M, Deuther-Conrad W, Wenzel B, Cumming P, Toussaint M, Ludwig F-A, Moldovan R-P, Kranz M, Teodoro R: Preclinical Evaluation of [18F] FACH in Healthy Mice and Piglets: An 18F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET. International journal of molecular sciences 2021, 22(4):1645.
  194. Günther T: Novel GRPR-targeted antagonists with improved pharmacokinetics for imaging and therapy of GRPR-expressing malignancies. Technische Universität München; 2021.
  195. Guttman ZR: Impulsivity or Aversion to Ambiguity? Decision-Making under Uncertainty in Stimulant Use Disorder. University of California, Los Angeles; 2021.
  196. Hack RI, Becker AS, Bode-Lesniewska B, Exner GU, Müller DA, Ferraro DA, Warnock GI, Burger IA, Britschgi C: When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma. Life 2021, 11(9):869.
  197. Haider A, Bengs S, Diggelmann F, Epprecht G, Etter D, Beeler AL, Wijnen WJ, Treyer V, Portmann A, Warnock GI: Age-and sex-dependent changes of resting amygdalar activity in individuals free of clinical cardiovascular disease. Journal of Nuclear Cardiology 2021, 28(2):427-432.
  198. Han Y-H, Jeong H-J, Kim E-M, Boud F, Lim ST, Lee SY, Sohn M-H: Effect of Ursodeoxycholic Acid on the Biodistribution and Excretion of Technetium-99m Radiopharmaceuticals in Rat: A Potential Image Quality Enhancer. Yonsei Medical Journal 2021, 62(6):555.
  199. Hashimoto F, Ohba H, Ote K, Kakimoto A, Tsukada H, Ouchi Y: 4D deep image prior: Dynamic PET image denoising using an unsupervised four-dimensional branch convolutional neural network. Physics in Medicine & Biology 2021, 66(1):015006.
  200. Hatano M, Miyazaki T, Ishiwata Y, Nakajima W, Arisawa T, Kuroki Y, Kobayashi A, Takada Y, Ogawa M, Kawamura K: Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor,[11 C] K-2, in healthy human subjects. Scientific reports 2021, 11(1):1-10.
  201. Hatashita S, Wakebe D: Longitudinal assessment of amyloid-beta deposition in initially amyloid-negative non-demented individuals with [11C]-PIB PET imaging. Medicine 2021, 100(35).
  202. Hattori Y, Matsuda S, Baba R, Matsumiya K, Iwasaki S, Constantinescu CC, Morley TJ, Carroll VM, Papin C, Gouasmat A: Design, Synthesis, and Evaluation of (2-Aminocyclopropyl) phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain. Journal of Medicinal Chemistry 2021, 64(7):3780-3793.
  203. Hayashi H, Kobayashi R, Kawakatsu S, Ohba M, Morioka D, Otani K: Comparison of the decreases in regional cerebral blood flow in the posterior cingulate cortex, precuneus, and parietal lobe between suspected non‐Alzheimer’s disease pathophysiology and Alzheimer’s disease. Psychogeriatrics 2021.
  204. Heing‐Becker I, Grötzinger C, Beindorff N, Prasad S, Erdmann S, Exner S, Haag R, Licha K: A Cyanine‐Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation. ChemBioChem 2021, 22(7):1307.
  205. Hirabayashi T, Nagai Y, Hori Y, Inoue K-i, Aoki I, Takada M, Suhara T, Higuchi M, Minamimoto T: Chemogenetic sensory fMRI reveals behaviorally relevant bidirectional changes in primate somatosensory network. Neuron 2021, 109(20):3312-3322. e3315.
  206. Hori Y, Nagai Y, Mimura K, Suhara T, Higuchi M, Bouret S, Minamimoto T: D1-and D2-like receptors differentially mediate the effects of dopaminergic transmission on cost/benefit evaluation and motivation in monkeys. bioRxiv 2021:2020.2011. 2027.400911.
  207. Horimoto Y, Sato C, Inagaki A, Hayashi E, Nozue T, Morita S, Kondo Y, Funaki M, Iida A, Tajima T: Effects of repetitive transcranial magnetic stimulation on cerebral glucose metabolism. Neurological Sciences 2021:1-5.
  208. Hsu J-W, Nien C-Y, Chen H-W, Tsai F-Y, Yeh S-C, Kao Y-H, Tsou T-C: Di (2-ethylhexyl) phthalate exposure exacerbates metabolic disorders in diet-induced obese mice. Food and Chemical Toxicology 2021, 156:112439.
  209. Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG: 18F-labeled radiotracers for In Vivo imaging of DREADD with positron emission tomography. European Journal of Medicinal Chemistry 2021, 213:113047.
  210. Huang CW, Chang YC, Hsiao HY, Liu JW, Chang FCS, Huang JJ: Creation of a rat lymphedema model using extensive lymph node dissection and circumferential soft tissue resection: Is this a reliable model? Microsurgery 2021, 41(8):762-771.
  211. Huang K-L, Hsiao T, Chang T-Y, Yang S-Y, Chang Y-J, Wu H-C, Liu C-H, Wu Y-M, Lin K-J, Ho M-Y: Neurodegeneration and Vascular Burden on Cognition After Midlife: A Plasma and Neuroimaging Biomarker Study. Frontiers in Human Neuroscience 2021, 15.
  212. Huang S, Wu Y, Li C, Xu L, Huang J, Huang Y, Cheng W, Xue B, Zhang L, Liang S: Tailoring morphologies of mesoporous polydopamine nanoparticles to deliver high-loading radioiodine for anaplastic thyroid carcinoma imaging and therapy. Nanoscale 2021, 13(35):15021-15030.
  213. Huang S, Zhang L, Xu M, Li C, Fu H, Huang J, Jin X, Liang S, Wang H: Co‐Delivery of 131I and Prima‐1 by Self‐Assembled CD44‐Targeted Nanoparticles for Anaplastic Thyroid Carcinoma Theranostics. Advanced Healthcare Materials 2021, 10(3):2001029.
  214. Hugon G, Goutal S, Dauba A, Breuil L, Larrat B, Winkeler A, Novell A, Tournier N: [18F] 2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood–Brain Barrier Permeability Induced by Focused Ultrasound. Pharmaceutics 2021, 13(11):1752.
  215. Hugon G, Goutal S, Dauba A, Breuil L, Winkeler A, Novell A, Tournier N: [18F] 2-fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Estimation of Blood-brain Barrier Permeability in vivo. 2021.
  216. Hwang J-H, Han Y-H, Rahman M, Lee C-S: Quantitative assessment of dry mouth in scrub typhus using salivary scintigraphy. Scientific reports 2021, 11(1):1-7.
  217. Iikuni S, Okada Y, Shimizu Y, Watanabe H, Ono M: Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. Molecular Pharmaceutics 2021, 18(3):966-975.
  218. Ikoma Y, Takuwa H, Nishino A, Maeda J, Kawamura K, Obata T, Zhang M-R, Higuchi M, Suhara T: Measurement of changes in endogenous serotonin level by positron emission tomography with [18F] altanserin. Annals of Nuclear Medicine 2021:1-11.
  219. Imanli H, Smith M, Mahat J, Chen W, Restrepo AJ, Sawan MA, Abdelmegid MA-KF, Abd el Rahman Helmy H, Demitry S, See V: Metabolic Scar Assessment with 18F-FDG-PET: Correlation to Ischemic VT Substrate and Successful Ablation Sites. Journal of Nuclear Medicine 2021.
  220. Inubushi T, Ito M, Mori Y, Futatsubashi M, Sato K, Ito S, Yokokura M, Shinke T, Kameno Y, Kakimoto A: Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release. NeuroImage 2021, 224:117434.
  221. Ishibashi K, Miura Y, Wagatsuma K, Kameyama M, Ishii K: Brain 11C‐ITMM PET to longitudinally assess type 1 metabotropic glutamate receptor availability in Alzheimer’s disease. Journal of Neuroimaging 2021.
  222. Jacques S, Arjomand A, Perée H, Collins P, Mayer A, Lavergne A, Wéry M, Mni M, Hego A, Thuillier V: Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma. Scientific reports 2021, 11(1):1-15.
  223. Jantarato A, Vachatimanont S, Boonkawin N, Yaset S, Kunawudhi A, Promteangtrong C, Assanasen J, Mahanonda N, Chotipanich C: The Evaluation of Tau Deposition with [18F] PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease. Molecular Imaging 2021, 2021.
  224. Jensen JB, Dollerup OL, Moeller AB, Billeskov TB, Dalbram E, Chubanava S, Dellinger RW, Trost K, Moritz T, Ringgaard S: A randomized placebo-controlled clinical trial of Nicotinamide Riboside and Pterostilbene supplementation in experimental muscle injury in elderly subjects. medRxiv 2021.
  225. Jeong EH, Sunwoo MK, Hyung SW, Han S-K, Lee JY: Correlation of Dopaminergic Denervation and the Progression of Autonomic Dysfunctions in Different Clinical Subtypes of Parkinson’s Disease. Parkinson’s Disease 2021, 2021.
  226. Jeong YJ, Park HS, Jeong JE, Yoon HJ, Jeon K, Cho K, Kang D-Y: Restoration of amyloid PET images obtained with short-time data using a generative adversarial networks framework. Scientific reports 2021, 11(1):1-11.
  227. Jeschke J, Collignon E, Al Wardi C, Krayem M, Bizet M, Jia Y, Garaud S, Wimana Z, Calonne E, Hassabi B: Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors. Nature Cancer 2021, 2(6):611-628.
  228. Ji B, Ono M, Yamasaki T, Fujinaga M, Zhang M-R, Seki C, Aoki I, Kito S, Sawada M, Suhara T: Detection of Alzheimer’s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X21992457.
  229. Jiang H, Joshi S, Liu H, Mansor S, Qiu L, Zhao H, Whitehead T, Gropler RJ, Wu GF, Cross AH: In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H] CS1P1 and [11C] CS1P1. ACS Chemical Neuroscience 2021, 12(19):3733-3744.
  230. Jiang M, Chen X, Zhang L, Liu W, Yu X, Wang Z, Zheng M: Electroacupuncture suppresses glucose metabolism and GLUT-3 expression in medial prefrontal cortical in rats with neuropathic pain. Biological Research 2021, 54(1):1-9.
  231. Johannessen K, Berntsen EM, Johansen H, Solheim TS, Karlberg A, Eikenes L: 18 F-FACBC PET/MRI in the evaluation of human brain metastases: a case report. European Journal of Hybrid Imaging 2021, 5(1):1-12.
  232. Joo Y-H, Kim J-H, Kim H-K, Son Y-D, Cumming P, Kim J-H: Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study. Life 2021, 11(6):506.
  233. Joya A, Ardaya M, Montilla A, Garbizu M, Plaza-García S, Gómez-Vallejo V, Padro D, Gutiérrez JJ, Rios X, Ramos-Cabrer P: In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke. Theranostics 2021, 11(1):410.
  234. Juri C, Kramer V, Riss PJ, Soza-Ried C, Haeger A, Pruzzo R, Rösch F, Amaral H, Chana-Cuevas P: [18F] PR04. MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease. Clinical nuclear medicine 2021, 46(2):119.
  235. Kaewchur T, Chamroonrat W, Thientunyakit T, Khiewvan B, Wongsurawat N, Chotipanich C, Chinvarun Y, Bunyaratavej K, Amnuaywattakorn S, Poon-iad N: Thai National Guideline for Nuclear Medicine Investigation in Epilepsy. Asia Oceania Journal of Nuclear Medicine and Biology 2021.
  236. Kagitani-Shimono K, Kato H, Kuwayama R, Tominaga K, Nabatame S, Kishima H, Hatazawa J, Taniike M: Clinical evaluation of neuroinflammation in child-onset focal epilepsy: a translocator protein PET study. Journal of Neuroinflammation 2021, 18(1):1-13.
  237. Kang KJ, Oh SJ, Nam KR, Ahn H, Park J, Lee KC, Choi JY: Validation of Image Qualities of a Novel Four-Mice Bed PET System as an Oncological and Neurological Analysis Tool. Journal of Imaging 2021, 7(3):43.
  238. Kang Y, Pandya S, Zinger N, Michaelson N, Gauthier SA: Longitudinal change in TSPO PET imaging in progressive multiple sclerosis. Annals of clinical and translational neurology 2021, 8(8):1755-1759.
  239. Kapoor S, Kala D, Svoboda J, Brnoliakova Z, Otahal J: The Effect of Sulphoraphane on Brain Glucose Uptake during Neonatal Hypoxic-Ischemic Encephalopathy in Newborn Rats. European Pharmaceutical Journal 2021, 68(1):136-138.
  240. Karlsson H, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Preoperative mu-opioid receptor availability predicts weight loss following bariatric surgery. medRxiv 2021.
  241. Karlsson HK, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Mesolimbic opioid-dopamine interaction is disrupted in obesity but recovered by weight loss following bariatric surgery. Translational Psychiatry 2021, 11(1):1-7.
  242. Karlsson HK, Tuominen L, Helin S, Salminen P, Nuutila P, Nummenmaa L: Preoperative brain μ-opioid receptor availability predicts weight development following bariatric surgery in women. JCI insight 2021, 6(10).
  243. Katayama D, Yanagawa M, Matsunaga K, Watabe H, Watabe T, Kato H, Kijima T, Takeda Y, Kumanogoh A, Shimosegawa E: Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival. Scientific reports 2021, 11(1):1-8.
  244. Kato H, Okuno T, Isohashi K, Koda T, Shimizu M, Mochizuki H, Nakatsuji Y, Hatazawa J: Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET. Journal of Cerebral Blood Flow & Metabolism 2021, 41(2):369-379.
  245. Kersemans V, Gilchrist S, Allen PD, Wallington S, Kinchesh P, Prentice J, Tweedie M, Warner JH, Smart SC: A System-Agnostic, Adaptable and Extensible Animal Support Cradle System for Cardio-Respiratory-Synchronised, and Other, Multi-Modal Imaging of Small Animals. Tomography 2021, 7(1):39-54.
  246. Kersting D, Jentzen W, Fragoso Costa P, Sraieb M, Sandach P, Umutlu L, Conti M, Zarrad F, Rischpler C, Fendler W: Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124. Scientific Reports 2021, 11(1):1-15.
  247. Kessler L, Kupusovic J, Ferdinandus J, Hirmas N, Umutlu L, Zarrad F, Nader M, Fendler WP, Totzeck M, Wakili R: Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET. Clinical Nuclear Medicine 2021, 46(10):807-813.
  248. Kim D, Moon BS, Park SM, Lee SJ, Kang SY, Park S, Oh SJ, Kim BS, Yoon H-J: Feasibility of TSPO-Specific Positron Emission Tomography Radiotracer for Evaluating Paracetamol-Induced Liver Injury. Diagnostics 2021, 11(9):1661.
  249. Kim D-Y, Min J-J: Synthesis and Evaluation of 18 F-Labeled Fluoroalkyl Triphenylphosphonium Salts as Mitochondrial Voltage Sensors in PET Myocardial Imaging. In: Mitochondrial Medicine. edn.: Springer; 2021: 49-64.
  250. Kim H-S, Lee B-i, Ahn J-S: Assessment of MicroPET Image Quality Based on Reconstruction Methods and Post-Filtering. Applied Sciences 2021, 11(18):8707.
  251. Kim J-H, Son Y-D, Kim H-K, Kim J-H: Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C] DASB. Neuropsychiatric Disease and Treatment 2021, 17:3195.
  252. Kim K, Choi H-y, Pak K, Jeon H: Changes in brain glucose metabolism following traumatic optic neuropathy in rats. All Life 2021, 14(1):49-57.
  253. Kim M, Kim E-M, Oh P-S, Lim ST, Sohn M-H, Song E-K, Park KU, Kim JY, Won KS, Jeong H-J: Usefulness of cyclic thermal therapy and red blood cell scintigraphy in patients with chemotherapy-induced peripheral neuropathy. The Korean Journal of Pain 2021, 34(4):427.
  254. Kimura K, Nagai Y, Hatanaka G, Fang Y, Zheng A, Fujiwara M, Nakano M, Hori Y, Takeuchi R, Inagaki M: A mosaic adeno-associated virus vector as a versatile tool that exhibits high levels of transgene expression and neuron specificity in primate brain. bioRxiv 2021.
  255. Kimura Y, Takahata K, Shimazaki T, Kitamura S, Seki C, Ikoma Y, Ichise M, Kawamura K, Yamada M, Zhang M-R: Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand,[11C] TASP457. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-9.
  256. Kinzi J, Grube M, Zu Schwabedissen HEM: OATP2B1-the underrated member of the Organic Anion Transporting Polypeptide Family of drug transporters? Biochemical Pharmacology 2021:114534.
  257. Kiraga Ł, Kucharzewska P, Paisey S, Cheda Ł, Domańska A, Rogulski Z, Rygiel TP, Boffi A, Król M: Nuclear imaging for immune cell tracking in vivo–Comparison of various cell labeling methods and their application. Coordination Chemistry Reviews 2021, 445:214008.
  258. Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM: PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook. Frontiers in oncology 2021, 11.
  259. Kjærgaard K, Frisch K, Sørensen M, Munk OL, Hofmann AF, Horsager J, Schacht AC, Erickson M, Shapiro D, Keiding S: Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. Journal of Hepatology 2021, 74(1):58-65.
  260. Klein J, Yan X, Johnson A, Tomljanovic Z, Zou J, Polly K, Honig LS, Brickman AM, Stern Y, Devanand D: Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer’s disease. Journal of Alzheimer’s Disease 2021(Preprint):1-16.
  261. Klinge MW, Sutter N, Mark EB, Haase A-M, Borghammer P, Schlageter V, Lund S, Fleischer J, Knudsen K, Drewes AM: Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy. Journal of Neurogastroenterology and Motility 2021, 27(3):390-399.
  262. Kobayashi M, Mizutani A, Okamoto T, Muranaka Y, Nishi K, Nishii R, Shikano N, Nakanishi T, Tamai I, Kleinerman ES: Assessment of drug transporters involved in the urinary secretion of [99mTc] dimercaptosuccinic acid. Nuclear Medicine and Biology 2021, 94:92-97.
  263. Koike T, Constantinescu CC, Ikeda S, Nishi T, Sunahara E, Miyamoto M, Cole P, Barret O, Alagille D, Papin C: Preclinical characterization of [18F] T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-9.
  264. Kojima K, Hirano S, Kimura Y, Seki C, Ikoma Y, Takahata K, Ito T, Yokokawa K, Hashimoto H, Kawamura K: Serotonergic neural network related to behavioral inhibition system. bioRxiv 2021.
  265. Kolinger GD, García DV, Lohith TG, Hostetler ED, Sur C, Struyk A, Boellaard R, Koole M: A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F] MK-6240. EJNMMI research 2021, 11(1):1-13.
  266. Kolinger GD, Vállez García D, Willemsen AT, Reesink FE, de Jong BM, Dierckx RA, De Deyn PP, Boellaard R: Amyloid burden quantification depends on PET and MR image processing methodology. PloS one 2021, 16(3):e0248122.
  267. Kong X, Luo S, Wang YF, Yang GF, Lu GM, Zhang LJ: [18F] PBR146 and [18F] DPA-714 in vivo Imaging of Neuroinflammation in Chronic Hepatic Encephalopathy Rats. Frontiers in Neuroscience 2021:1056.
  268. Kong Y, Huang L, Li W, Liu X, Zhou Y, Liu C, Zhang S, Xie F, Zhang Z, Jiang D: The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment. Frontiers in cell and developmental biology 2021, 9.
  269. Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, Schroeder FA, Hooker JM, Bormans G, de Hoon J: Clinical validation of the novel HDAC6 radiotracer [18 F] EKZ-001 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(2):596-611.
  270. Kranz GS, Spies M, Vraka C, Kaufmann U, Klebermass E-M, Handschuh PA, Ozenil M, Murgaš M, Pichler V, Rischka L: High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report. Psychoneuroendocrinology 2021, 133:105381.
  271. Kreuzer A, Sauerbeck J, Scheifele M, Stockbauer A, Schönecker S, Prix C, Wlasich E, Loosli SV, M Kazmierczak P, Unterrainer M: Detection gap of right-asymmetric neuronal degeneration by CERAD test battery in Alzheimer’s disease. Frontiers in Aging Neuroscience 2021, 13:5.
  272. Kubota M, Seki C, Kimura Y, Takahata K, Shimada H, Takado Y, Matsuoka K, Tagai K, Sano Y, Yamamoto Y: A first-in-human study of 11 C-MTP38, a novel PET ligand for phosphodiesterase 7. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
  273. Kühnel C, Seifert P, Drescher R, Freesmeyer M: Reframing multiple reconstructed early dynamic PET images for smooth image rendering. Nuklearmedizin 2021, 60(02):P15.
  274. Kupitz D, Wissel H, Wuestemann J, Bluemel S, Pech M, Amthauer H, Kreissl MC, Grosser OS: Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT. EJNMMI physics 2021, 8(1):1-14.
  275. Kwon IG, Kang CW, Park J-P, Oh JH, Wang EK, Kim TY, Sung JS, Park N, Lee YJ, Sung H-J: Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment. Gut 2021, 70(10):1847-1856.
  276. Labrador-Espinosa MA, Grothe MJ, Macías-García D, Jesús S, Adarmes-Gómez A, Muñoz-Delgado L, Fernández-Rodríguez P, Martín-Rodríguez JF, Huertas I, García-Solís D: Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum. Clinical Nuclear Medicine 2021, 46(6):e296-e306.
  277. Lahnif H, Grus T, Pektor S, Greifenstein L, Schreckenberger M, Rösch F: Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach. Molecules 2021, 26(21):6332.
  278. Lai TH, Schröder S, Toussaint M, Dukić-Stefanović S, Kranz M, Ludwig F-A, Fischer S, Steinbach J, Deuther-Conrad W, Brust P: Development of 18F-labeled radiotracers for PET imaging of the adenosine A2A receptor: Synthesis, radiolabeling and preliminary biological evaluation. International journal of molecular sciences 2021, 22(5):2285.
  279. Lai TH, Toussaint M, Teodoro R, Dukić-Stefanović S, Gündel D, Ludwig F-A, Wenzel B, Schröder S, Sattler B, Moldovan R-P: Improved in vivo PET imaging of the adenosine A 2A receptor in the brain using [18 F] FLUDA, a deuterated radiotracer with high metabolic stability. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
  280. Lai TH, Toussaint M, Teodoro R, Dukić-Stefanović S, Kranz M, Deuther-Conrad W, Moldovan R-P, Brust P: Synthesis and biological evaluation of a novel 18F-labeled radiotracer for PET imaging of the adenosine A2A receptor. International journal of molecular sciences 2021, 22(3):1182.
  281. Lan Y, Bai P, Liu Y, Afshar S, Striar R, Rattray AK, Meyer TN, Langan AG, Posner AM, Shen S: Visualization of Receptor-Interacting Protein Kinase 1 (RIPK1) by Brain Imaging with Positron Emission Tomography. Journal of Medicinal Chemistry 2021, 64(20):15420-15428.
  282. Landau AM, Lillethorup TP, Noer O, Alstrup AKO, Stokholm K, Thomsen MB, Zaer H, Orlowski D, Mikkelsen TW, Glud AN: Spontaneous Partial Recovery of Striatal Dopaminergic Uptake Despite Nigral Cell Loss in Asymptomatic MPTP-Lesioned Minipigs. 2021.
  283. Langaa SS, Lauridsen TG, Mose FH, Fynbo CA, Theil J, Bech JN: Estimation of renal perfusion based on measurement of rubidium-82 clearance by PET/CT scanning in healthy subjects. EJNMMI physics 2021, 8(1):1-20.
  284. Latorre Moreno L: Image processing software for seizure onset zone localization in refractory epilepsy. 2021.
  285. Laymon CM, Minhas DS, Royse SK, Aizenstein HJ, Cohen AD, Tudorascu DL, Klunk WE: Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [11C] PiB amyloid imaging. EJNMMI physics 2021, 8(1):1-16.
  286. Ledermann K, von Känel R, Berna-Renella C, Sprott H, Jenewein J, Garland E, Martin-Sölch C: Understanding And Restoring Dopaminergic Function In Fibromyalgia Patients Using A Mindfulness-Based Psychological Intervention: A [18F]-DOPA PET StudyStudy Protocol For The FIBRODOPA Study-A Randomized Controlled Trial. 2021.
  287. Lee B-C, Tsai H-H, Huang AP-H, Lo Y-L, Tsai L-K, Chen Y-F, Wu W-C: Arterial Spin Labeling Imaging Assessment of Cerebrovascular Reactivity in Hypertensive Small Vessel Disease. Frontiers in Neurology 2021, 12:1004.
  288. Lee C-C, Liao Y-C, Lee M-C, Lin K-J, Hsu H-Y, Chiou S-Y, Young S-L, Lin J-S, Huang C-C, Watanabe K: Lactobacillus plantarum TWK10 attenuates aging-associated muscle weakness, bone loss, and cognitive impairment by modulating the gut microbiome in mice. Frontiers in nutrition 2021:753.
  289. Lee C-H, Choi Y-A, Heo S-J, Song P: The Effect of Hyperbaric Therapy on Brown Adipose Tissue in Rats. International journal of environmental research and public health 2021, 18(17):9165.
  290. Lee J-H, Veronese M, Liow J-S, Morse CL, Santamaria JAM, Haskali MB, Zoghbi SS, Pike VW, Innis RB, Zanotti-Fregonara P: Region-and voxel-based quantification in human brain of [18 F] LSN3316612, a radioligand for O-GlcNAcase. EJNMMI research 2021, 11(1):1-9.
  291. Lee JW, Song YS, Kim H, Ku BD, Lee WW: Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data. Plos one 2021, 16(2):e0246881.
  292. Lee JW, Song YS, Kim H, Ku BD, Lee WW: Methodological considerations of evaluating the rate of presynaptic dopaminergic denervation in Parkinson disease with radiotracers: Analysis of the PPMI data. Medicine 2021, 100(26).
  293. Lee MJ, Pak K, Kim H-K, Nudelman KN, Kim JH, Kim YH, Kang J, Baek MS, Lyoo CH: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease. npj Parkinson’s Disease 2021, 7(1):1-9.
  294. Lee N, Oh S-J, Park J-W, Nam K-R, Kang K-J, Lee K-C, Lee Y-J, Choi J-S, Seok J-H, Choi J-Y: Evaluation of the Effects of Developmental Trauma on Neurotransmitter Systems Using Functional Molecular Imaging. International journal of molecular sciences 2021, 22(5):2522.
  295. Lee S, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH: Radiosynthesis and characterization of [18F] BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism. Eur J Nucl Med Mol Imaging 2021.
  296. Lehner E, Menzel M, Gündel D, Plontke SK, Mäder K, Klehm J, Kielstein H, Liebau A: Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear. Drug Delivery and Translational Research 2021:1-10.
  297. Lenka A, Lamotte G, Goldstein DS: Cardiac 18F‐Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA. Movement Disorders Clinical Practice 2021, 8(4):582-586.
  298. Lerche CW, Radomski T, Lohmann P, Caldeira L, Brambilla CR, Tellmann L, Scheins J, Kops ER, Galldiks N, Langen K-J: A Linearized Fit Model for Robust Shape Parameterization of FET-PET TACs. IEEE Transactions on Medical Imaging 2021.
  299. Lhamyani S, Gentile A-M, Giráldez-Pérez RM, Feijóo-Cuaresma M, Romero-Zerbo SY, Clemente-Postigo M, Zayed H, Oliva-Olivera W, Bermúdez-Silva FJ, Salas J: miR-21 mimic blocks obesity in mice: A novel therapeutic option. Molecular Therapy-Nucleic Acids 2021, 26:401-416.
  300. Li E, Spencer BA, Schmall JP, Abdelhafez Y, Badawi RD, Wang G, Cherry SR: Efficient delay correction for total-body PET kinetic modeling using pulse timing methods. Journal of Nuclear Medicine 2021.
  301. Li J, Zheng C, Ge Q, Yan S, Paranjpe MD, Hu S, Zhou Y, Initiative AsDN: Association between long‐term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using 18F‐AV‐45 and 18F‐AV‐1451 PET. Journal of neuroscience research 2021.
  302. Li M-H, Lo S-N, Chen M-W, Lo W-L, Huang Y-R, Lee S-Y, Chen S-J, Lo S-W, Wang S-M, Chang C-H: Molecular Imaging for Radiolabeling a PSMA-Targeted Long Circulating Peptide as a Theranostic Agent in Mice Bearing a Human Prostate Tumor. Journal of Medical and Biological Engineering 2021, 41(3):360-368.
  303. Li S, Daamen M, Scheef L, Gaertner FC, Buchert R, Buchmann M, Buerger K, Catak C, Dobisch L, Drzezga A: Abnormal regional and global connectivity measures in subjective cognitive decline depending on cerebral amyloid status. Journal of Alzheimer’s Disease 2021(Preprint):1-17.
  304. Li W, Wang Y, Rubins D, Bennacef I, Holahan M, Haley H, Purcell M, Gantert L, Hseih S, Judo M: PET/CT Imaging of 89 Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys. Molecular imaging and biology 2021, 23(2):250-259.
  305. Li Y, Liu K, Li C, Guo Y, Fang J, Tong H, Tang Y, Zhang J, Sun J, Jiao F: 18F-FDG PET Combined With MR Spectroscopy Elucidates the Progressive Metabolic Cerebral Alterations After Blast-Induced Mild Traumatic Brain Injury in Rats. Frontiers in neuroscience 2021, 15:243.
  306. Li Z, Kaiser L, Holzgreve A, Ruf VC, Suchorska B, Wenter V, Quach S, Herms J, Bartenstein P, Tonn J-C: Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F] FET PET radiomics. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48(13):4415-4425.
  307. Liang K, Abt ER, Le TM, Cho A, Dann AM, Cui J, Li L, Rashid K, Creech AL, Wei L: STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F] FLT PET imaging. Proceedings of the National Academy of Sciences 2021, 118(36).
  308. Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH: Positron Emission Tomographic imaging of tumor cell death using Zirconium-89-labeled APOMAB® following cisplatin chemotherapy in lung and ovarian cancer xenograft models. Molecular Imaging and Biology 2021:1-15.
  309. Lien VT, Celen S, Nuruddin S, Attili B, Doumont G, Van Simaeys G, Bormans G, Klaveness J, Olberg DE: Preclinical evaluation of [18F] cabozantinib as a PET imaging agent in a prostate cancer mouse model. Nuclear medicine and biology 2021, 93:74-80.
  310. Lin C-Y, Wu R-C, Huang C-Y, Lai C-H, Chao A-S, Li H-P, Tsai C-L, Kuek EJ-W, Hsu C-L, Chao A: A Patient-Derived Xenograft Model of Dedifferentiated Endometrial Carcinoma: A Proof-of-Concept Study for the Identification of New Molecularly Informed Treatment Approaches. Cancers 2021, 13(23):5962.
  311. Lin J-J, Chuang C-P, Lin J-Y, Huang F-T: Development and preclinical evaluation of [68Ga] Ga-Alb-FAPtp-01, a novel tumour-associated fibroblast activation protein tracer for PET imaging of xenograft glioma. 2021.
  312. Lin J-J, Chuang C-P, Lin J-Y, Huang F-T, Huang C-W: Rational Design, Pharmacomodulation, and Synthesis of [68Ga] Ga-Alb-FAPtp-01, a Selective Tumor-Associated Fibroblast Activation Protein Tracer for PET Imaging of Glioma. ACS sensors 2021, 6(9):3424-3435.
  313. Lin S-H, Chi MH, Lee IH, Chen KC, Tai YC, Yao WJ, Chiu NT, Yang D-Y, Lin C-Y, Chen PS: A pilot study on the association between the blood oxygen level-dependent signal in the reward system and dopamine transporter availability in adults with attention deficit hyperactivity disorder. CNS spectrums 2021, 26(3):299-306.
  314. Lindberg A, Knight AC, Sohn D, Rakos L, Tong J, Radelet A, Mason NS, Stehouwer JS, Lopresti BJ, Klunk WE: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F] CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies. ACS Chemical Neuroscience 2021, 12(4):596-602.
  315. Lisec J, Kobelt D, Walther W, Mokrizkij M, Grötzinger C, Jaeger C, Baum K, Simon M, Wolf J, Beindorff N: Systematic identification of MACC1-driven metabolic networks in colorectal cancer. Cancers 2021, 13(5):978.
  316. Liu G, Yu H, Shi D, Hu P, Hu Y, Tan H, Zhang Y, Yin H, Shi H: Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of 18F-FDG in healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-11.
  317. Liu L, Johnson PD, Prime ME, Khetarpal V, Lee MR, Brown CJ, Chen X, Clark-Frew D, Coe S, Conlon M: [11C] CHDI-626, a PET tracer candidate for imaging mutant Huntingtin aggregates with reduced binding to AD pathological proteins. Journal of Medicinal Chemistry 2021, 64(16):12003-12021.
  318. Liu Y, Hong H, Xue J, Luo J, Liu Q, Chen X, Pan Y, Zhou J, Liu Z, Chen T: Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood–Brain Barrier Crossing and Protection for Parkinsonian Therapy. ACS Applied Materials & Interfaces 2021, 13(31):37746-37760.
  319. Liu Z, Cheng T, Düwel S, Jian Z, Topping GJ, Steiger K, Wang Q, Braren R, Reder S, Mittelhäuser M: Proof of Concept of a Multimodal Intravital Molecular Imaging System for Tumour Transpathology Investigation. 2021.
  320. Loeffler J, Koch A, Hamp C, Solbach C, Li H, Glatting G, Rasche V, Beer A, Winter G: Evaluation of the biodistribution of 18F-siPSMA-14 in the HET-CAM model. In.: Soc Nuclear Med; 2021.
  321. Loenen AC, Peters MJ, Wierts R, Bevers RT, van Rhijn LW, Arts JJ, Willems PC: Local bone metabolism during the consolidation process of spinal interbody fusion. Journal of Bone and Mineral Metabolism 2021:1-9.
  322. Löffler J, Hamp C, Scheidhauer E, Di Carlo D, Solbach C, Abaei A, Hao L, Glatting G, Beer AJ, Rasche V: Comparison of Quantification of Target-Specific Accumulation of [18F] F-siPSMA-14 in the HET-CAM Model and in Mice Using PET/MRI. Cancers 2021, 13(16):4007.
  323. Lombardi G, Spimpolo A, Berti S, Campi C, Anglani MG, Simeone R, Evangelista L, Causin F, Zorzi G, Gorgoni G: PET/MR in recurrent glioblastoma patients treated with regorafenib:[18F] FET and DWI-ADC for response assessment and survival prediction. The British Journal of Radiology 2021, 95(1129):20211018.
  324. López-Vega JM, Álvarez I, Antón A, Illarramendi JJ, Llombart A, Boni V, García-Velloso MJ, Martí-Climent JM, Pina L, García-Foncillas J: Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer. Cancers 2021, 13(14):3511.
  325. Löser J, Luthardt J, Rullmann M, Weise D, Sabri O, Meixensberger J, Hesse S, Winkler D: Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson’s disease. Journal of Neurosurgery 2021, 1(aop):1-7.
  326. Lu M, Lindenberg L, Mena E, Turkbey B, Seidel J, Ton A, McKinney Y, Eclarinal P, Merino M, Pinto P: A Pilot Study of Dynamic 18F-DCFPyL PET/CT Imaging of Prostate Adenocarcinoma in High-Risk Primary Prostate Cancer Patients. Molecular Imaging and Biology 2021:1-9.
  327. Lue K-H, Chu S-C, Wang L-Y, Chen Y-C, Li M-H, Chang B-S, Chan S-C, Chen Y-H, Lin C-B, Liu S-H: Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma. Annals of Nuclear Medicine 2021:1-11.
  328. Luong TV, Pedersen MGB, Kjærulff MLBG, Madsen S, Lauritsen KM, Tolbod LP, Søndergaard E, Gormsen LC: Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study. Metabolism 2021, 123:154862.
  329. Luyten K, Van Loy T, Cawthorne C, Deroose CM, Schols D, Bormans G, Cleeren F: D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy. Pharmaceutics 2021, 13(10):1619.
  330. Ma X, Xiao W, Li H, Pang P, Xue F, Wan L, Pei L, Yan H: Metformin restores hippocampal neurogenesis and learning and memory via regulating gut microbiota in the obese mouse model. Brain, Behavior, and Immunity 2021.
  331. MacAskill MG, Stadulyte A, Williams L, Morgan TE, Sloan NL, Alcaide-Corral CJ, Walton T, Wimberley C, McKenzie C-A, Spath N: Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism. Journal of Nuclear Medicine 2021, 62(4):536-544.
  332. MacAskill MG, Wimberley C, Morgan TE, Alcaide-Corral CJ, Newby DE, Lucatelli C, Sutherland A, Pimlott SL, Tavares AA: Modelling [18F] LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-9.
  333. Malbert CH, Chauvin A, Horowitz M, Jones KL: Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals. Diabetes 2021, 70(1):99-110.
  334. Manell E, Puuvuori E, Svensson A, Velikyan I, Hulsart-Billström G, Hedenqvist P, Holst JJ, Waern MJ, Eriksson O: Exploring the GLP-1–GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography. BMJ Open Diabetes Research and Care 2021, 9(1):e002083.
  335. Mann LG, Hay KR, Song AK, Errington SP, Trujillo P, Zald DH, Yan Y, Kang H, Logan GD, Claassen DO: D2-Like Receptor Expression in the Hippocampus and Amygdala Informs Performance on the Stop-Signal Task in Parkinson’s Disease. Journal of Neuroscience 2021, 41(48):10023-10030.
  336. Mannheim JG, Cheng J-CK, Vafai N, Shahinfard E, English C, McKenzie J, Zhang J, Barlow L, Sossi V: Cross-validation study between the HRRT and the PET component of the SIGNA PET/MRI system with focus on neuroimaging. EJNMMI physics 2021, 8(1):1-22.
  337. Mapelli P, Callea M, Fallanca F, Castellano A, Bailo M, Scifo P, Bettinardi V, Conte GM, Monterisi C, Rancoita PMV: 18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: Correlation with hypoxia immunohistochemical biomarkers. Nuclear Medicine Communications 2021, 42(7):763-771.
  338. Marie S, Hernández-Lozano I, Breuil L, Truillet C, Hu S, Sparreboom A, Tournier N, Langer O: Imaging-Based Characterization of a Slco2b1 (-/-) Mouse Model Using [11C] Erlotinib and [99mTc] Mebrofenin as Probe Substrates. Pharmaceutics 2021, 13(6):918.
  339. Massa F, Bauckneht M, Peira E, Lapucci C, Picco A, Capitanio S, Arnaldi D, Roccatagliata L, Chincarini A, Nobili F: Neuroimaging findings in mild cognitive impairment. In: PET and SPECT in Neurology. edn.: Springer, Cham; 2021: 367-425.
  340. Matsuda S, Hattori Y, Matsumiya K, McQuade P, Yamashita T, Aida J, Sandiego CM, Gouasmat A, Carroll VM, Barret O: Design, Synthesis, and Evaluation of [18F] T-914 as a Novel Positron-Emission Tomography Tracer for Lysine-Specific Demethylase 1. Journal of Medicinal Chemistry 2021, 64(17):12680-12690.
  341. Matsumoto H, Watabe T, Igarashi C, Tachibana T, Hihara F, Waki A, Zhang M-R, Tashima H, Yamaya T, Ooe K: Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates. Pharmaceuticals 2021, 14(10):950.
  342. Mazzoletti A, Albano D, Bertagna F, Mesquita CT, Giubbini R: Comparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13 N-NH 3 PET/CT. Journal of Nuclear Cardiology 2021:1-6.
  343. McMurray L, Macdonald JA, Ramakrishnan NK, Zhao Y, Williamson DW, Tietz O, Zhou X, Kealey S, Fagan SG, Smolek T: Synthesis and assessment of novel probes for imaging tau pathology in transgenic mouse and rat models. ACS chemical neuroscience 2021, 12(11):1885-1893.
  344. Messerli M, Muehlematter UJ, Fassbind S, Franzen D, Ferraro DA, Huellner MW, Treyer V, Curioni-Fontecedro A, Burger IA: A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET. The British Journal of Radiology 2021, 94(1119):20200244.
  345. Meyer M, Lamare F, Asselineau J, Foubert‐Samier A, Mazère J, Zanotti‐Fregonara P, Rizzo G, Delamarre A, Spampinato U, Rascol O: Brain 5‐HT1A Receptor Binding in Multiple System Atrophy: An [18F]‐MPPF PET Study. Movement Disorders 2021, 36(1):246-251.
  346. Michalski K, Kemna L, Asberger J, Grosu AL, Meyer PT, Ruf J, Sprave T: Gastrin-Releasing Peptide Receptor Antagonist [68Ga] RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer. Cancers 2021, 13(23):6106.
  347. Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, Koole M, Lemmens R, Van Laere K: Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study. NeuroImage 2021, 232:117877.
  348. Michiels L, Mertens N, Thijs L, Radwan A, Sunaert S, Vandenbulcke M, Verheyden G, Koole M, Van Laere K, Lemmens R: Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211047759.
  349. Michiels L, Van Weehaeghe D, Vandenberghe R, Demeestere J, Van Laere K, Lemmens R: The Role of Amyloid PET in Diagnosing Possible Transmissible Cerebral Amyloid Angiopathy in Young Adults with a History of Neurosurgery: A Case Series. Cerebrovascular Diseases 2021, 50(3):356-360.
  350. Miller B, Vunnam R, Mesubi O, Smith MF, Chen W, Mahat JB, Bentzen SM, See V, Restrepo A, Shorofsky S: Metabolic Heterogeneous Zone Assessed by 18FDG‐PET is Predictive of Post‐Ablation Mortality in Patients with Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology 2021.
  351. Miranda A, Bertoglio D, Stroobants S, Staelens S, Verhaeghe J: Low activity [11C] raclopride kinetic modeling in the mouse brain using the spatiotemporal kernel method. Physics in Medicine & Biology 2021, 66(11):115005.
  352. Misslinger M, Petrik M, Pfister J, Hubmann I, Bendova K, Decristoforo C, Haas H: Desferrioxamine B-mediated pre-clinical in vivo imaging of infection by the mold fungus Aspergillus fumigatus. Journal of Fungi 2021, 7(9):734.
  353. Miyagawa S, Mizoguchi H, Fukushima S, Imanishi Y, Watabe T, Harada A, Sakai Y, Sawa Y: New regional drug delivery system by direct epicardial placement of slow-release prostacyclin agonist promise therapeutic angiogenesis in a porcine chronic myocardial infarction. Journal of Artificial Organs 2021:1-8.
  354. Mohamed-Ahmed S, Yassin MA, Rashad A, Espedal H, Idris SB, Finne-Wistrand A, Mustafa K, Vindenes H, Fristad I: Comparison of bone regenerative capacity of donor-matched human adipose–derived and bone marrow mesenchymal stem cells. Cell and Tissue Research 2021, 383(3):1061-1075.
  355. Mohammed F, He X, Lin Y: An easy-to-use deep-learning model for highly accurate diagnosis of Parkinson’s disease using SPECT images. Computerized Medical Imaging and Graphics 2021, 87:101810.
  356. Moldovan R-P, Gündel D, Teodoro R, Ludwig F-A, Fischer S, Toussaint M, Schepmann D, Wünsch B, Brust P, Deuther-Conrad W: Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant 18F-Labelled σ2 Receptor Ligand. International journal of molecular sciences 2021, 22(11):5447.
  357. Mondal R, Campoy A-DT, Liang C, Mukherjee J: [18F] FDG PET/CT studies in transgenic Hualpha-Syn (A53T) Parkinson’s disease mouse model of α-synucleinopathy. Frontiers in neuroscience 2021:718.
  358. Moon BS, Park HS, Sunwoo J, Lee IH, Kim A, Moon SJ, Lee H, Son MH, Kim SB, Park SM: Tissue pharmacokinetics of DHP107, a novel lipid‐based oral formulation of paclitaxel, in mice and patients by positron emission tomography. Clinical and Translational Science 2021.
  359. Moreno JM, Martinez CM, de Jodar C, Reverte V, Bernabé A, Salazar FJ, Llinás MT: Gender differences in the renal changes induced by a prolonged high-fat diet in rats with altered renal development. Journal of Physiology and Biochemistry 2021:1-11.
  360. Mori H, Taki J, Wakabayashi H, Hiromasa T, Inaki A, Ogawa K, Shiba K, Kinuya S: Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by 14 C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT. Annals of Nuclear Medicine 2021, 35(2):253-259.
  361. Mosleh-Shirazi MA, Nasiri-Feshani Z, Ghafarian P, Alavi M, Haddadi G, Ketabi A: Tumor volume-adapted SUV N as an alternative to SUV peak for quantification of small lesions in PET/CT imaging: a proof-of-concept study. Japanese Journal of Radiology 2021:1-13.
  362. Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog A-B, Revheim M-E: Evaluation of semi-quantitative measures of 18 F-Flutemetamol PET for the clinical diagnosis of Alzheimer’s disease. Quant Imaging Med Surg 2021.
  363. Müller L, Power Guerra N, Stenzel J, Rühlmann C, Lindner T, Krause BJ, Vollmar B, Teipel S, Kuhla A: Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice. Nutrients 2021, 13(3):985.
  364. Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, Nikula CJ, Dexter A, Murta T, Race AM: The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nature Genetics 2021, 53(1):16-26.
  365. Nakae R, Sekine T, Tagami T, Murai Y, Kodani E, Warnock G, Sato H, Morita A, Yokota H, Yokobori S: Rapidly progressive brain atrophy in septic ICU patients: a retrospective descriptive study using semiautomatic CT volumetry. Critical Care 2021, 25(1):1-9.
  366. Nakashima K, Iikuni S, Okada Y, Watanabe H, Shimizu Y, Nakamoto Y, Ono M: Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX. Nuclear Medicine and Biology 2021, 93:46-53.
  367. Nam H-Y, Seo S, Lee MJ, Kim K, Kim IJ, Pak K: No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjects. Nuklearmedizin-NuclearMedicine 2021, 60(06):434-437.
  368. Narayanaswami V, Tong J, Schifani C, Bloomfield PM, Dahl K, Vasdev N: Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation. PET clinics 2021, 16(2):233-247.
  369. Nascimento EB, Moonen MP, Remie CM, Gariani K, Jörgensen JA, Schaart G, Hoeks J, Auwerx J, van Marken Lichtenbelt WD, Schrauwen P: Nicotinamide riboside enhances in vitro beta-adrenergic brown adipose tissue activity in humans. The Journal of Clinical Endocrinology & Metabolism 2021, 106(5):1437-1447.
  370. Navalkar A, Pandey S, Singh N, Patel K, Datta D, Mohanty B, Jadhav S, Chaudhari P, Maji SK: Direct evidence of cellular transformation by prion-like p53 amyloid infection. Journal of Cell Science 2021, 134(11):jcs258316.
  371. Nguyen D, Zaitseva TS, Zhou A, Rochlin D, Sue G, Deptula P, Tabada P, Wan D, Loening A, Paukshto M: Lymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds: Preliminary preclinical and clinical results. Journal of Surgical Oncology 2021.
  372. Nguyen N: Characterizing the metabolic fate of (2S, 4R)-4-[18F] fluoroglutamine and its applications in cancer imaging and treatment response monitoring. 2021.
  373. Nguyen NTK, Chang Y-H, Truong VA, Hsu M-N, Pham NN, Chang C-W, Wu Y-H, Chang Y-H, Li H, Hu Y-C: CRISPR Activation of Long Non-coding RNA DANCR Promotes Bone Regeneration. Biomaterials 2021:120965.
  374. Ni R, Herde AM, Haider A, Keller C, Louloudis G, Vaas M, Schibli R, Ametamey SM, Klohs J, Mu L: In vivo imaging of cannabinoid type 2 receptors, functional and structural alterations in mouse model of cerebral ischemia by PET and MRI. bioRxiv 2021.
  375. Nihashi T, Sakurai K, Kato T, Iwata K, Kimura Y, Ikenuma H, Yamaoka A, Takeda A, Arahata Y, Washimi Y: Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer’s Disease Continuum. Journal of Alzheimer’s Disease 2021(Preprint):1-12.
  376. Nishibe H, Tateno A, Sakayori T, Yamamoto M, Kim W, Kakuyama H, Okubo Y: Striatal Dopamine D2 Receptor Occupancy Induced by Daily Application of Blonanserin Transdermal Patches: Phase II Study in Japanese Patients With Schizophrenia. International Journal of Neuropsychopharmacology 2021, 24(2):108-117.
  377. Novy Z, Janousek J, Barta P, Petrik M, Hajduch M, Trejtnar F: Preclinical evaluation of anti‐VEGFR2 monoclonal antibody ramucirumab labelled with zirconium‐89 for tumour imaging. Journal of Labelled Compounds and Radiopharmaceuticals 2021.
  378. Nuebling GS, Prix C, Brendel M, Beyer L, Wlasich E, Loosli SV, Barthel H, Sabri O, Bartenstein P, Vöglein J: Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease. Neurobiology of Aging 2021, 103:147. e141-147. e145.
  379. Obokata N, Seki C, Hirata T, Maeda J, Ishii H, Nagai Y, Matsumura T, Takakuwa M, Fukuda H, Minamimoto T: Synthesis and preclinical evaluation of [11 C] MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-12.
  380. Oh M, Lee N, Kim C, Son HJ, Sung C, Oh SJ, Lee SJ, Chung SJ, Lee CS, Kim JS: Diagnostic accuracy of dual-phase 18F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism. Scientific Reports 2021, 11(1):1-8.
  381. Okita K, Kato K, Shigemoto Y, Sato N, Matsumoto T, Matsuda H: Effects of an Adenosine A2A Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography. Frontiers in Neuroscience 2021:1173.
  382. Okonkwo DO, Puffer RC, Minhas DS, Beers SR, Edelman KL, Sharpless J, Laymon CM, Lopresti BJ, Benso S, Puccio AM: PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline. Neurotrauma Editor’s Pick 2021 2021.
  383. Oleshchuk D, Šálek P, Dvořáková J, Kučka J, Pavlova E, Francová P, Šefc L, Proks V: Biocompatible polypeptide nanogel: Effect of surfactants on nanogelation in inverse miniemulsion, in vivo biodistribution and blood clearance evaluation. Materials Science and Engineering: C 2021, 126:111865.
  384. Ono M, Takahashi M, Shimozawa A, Fujinaga M, Mori W, Nagai Y, Mimura K, Minamihisamatsu T, Uchida S, Kumata K: In vivo visualization of propagating α-synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05. bioRxiv 2021:2020.2010. 2023.349860.
  385. Onuki Y, Ono S, Nakajima T, Kojima K, Taga N, Ikeda T, Kuwajima M, Kurokawa Y, Kato M, Kawai K: Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency. Brain Communications 2021.
  386. Ørntoft NW, Gormsen LC, Keiding S, Munk OL, Ott P, Sørensen M: Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans. JHEP Reports 2021, 3(3):100288.
  387. Otaki Y, Manabe O, Miller RJ, Manrique A, Nganoa C, Roth N, Berman DS, Germano G, Slomka PJ, Agostini D: Quantification of myocardial blood flow by CZT-SPECT with motion correction and comparison with 15O-water PET. Journal of Nuclear Cardiology 2021, 28(4):1477-1486.
  388. Oyama K, Hori Y, Nagai Y, Miyakawa N, Mimura K, Hirabayashi T, Inoue K-i, Suhara T, Takada M, Higuchi M: Chemogenetic dissection of the primate prefronto-subcortical pathways for working memory and decision-making. Science Advances 2021, 7(26):eabg4246.
  389. Pajouhesh P, Fan A, Castillo J, Shen B, Cipriano P, Yoon D, Biswal S: Increased sigma-1 receptor binding observed in the pain matrix of patients suffering from chronic pain. In.: Soc Nuclear Med; 2021.
  390. Pak K, Lee MJ: SLC63 Gene Polymorphisms is Associated with Striatal Dopamine Transporter Changes after Glucose Loading. 2021.
  391. Pak K, Lee MJ, Kim K, Kim IJ: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects. Annals of Nuclear Medicine 2021, 35(11):1187-1192.
  392. Pak K, Seo S, Lee MJ, Im H-J, Kim K, Kim IJ: Limited predictive power of DAT mRNA mappings for DAT protein expressions. 2021.
  393. Pak K, Seo S, Lee MJ, Kim K, Suh S, Im H-J, Kim IJ: Striatal DAT availability does not change after supraphysiological glucose loading dose in humans. Endocrine Connections 2021, 10(10):1266-1272.
  394. Pak K, Seo S, Lee MJ, Kim K, Suh S, Lee J, Kim S-J, Kim IJ: Hedonic rating of sucrose is sub-regionally associated with striatal dopamine transporter in humans. Neuroendocrinology 2021.
  395. Pak K, Seok JW, Nam H-Y, Seo S, Lee MJ, Kim K, Kim IJ: The association of DAT gene methylation with striatal DAT availability in healthy subjects. EJNMMI research 2021, 11(1):1-6.
  396. Papadopoulos N, Beindorff N, Hoffmann S, Jost-Brinkmann P-G, Präger TM: Impact of piezocision on orthodontic tooth movement. Korean Journal of Orthodontics 2021, 51(6):366-374.
  397. Park DG, Kang J, An Y-S, Chang J, Yoon JH: Association of Plasma α-synuclein with Cardiac 123I-MIBG Scintigraphy in Early Parkinson’s Disease. Neuroscience Letters 2021:136399.
  398. Park DG, Kim JW, An Y-S, Chang J, Yoon JH: Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease. Journal of Neural Transmission 2021, 128(12):1853-1861.
  399. Pascual B, Funk Q, Zanotti-Fregonara P, Cykowski MD, Veronese M, Rockers E, Bradbury K, Yu M, Nakawah MO, Román GC: Neuroinflammation is highest in areas of disease progression in semantic dementia. Brain 2021, 144(5):1565-1575.
  400. Patterson R: Neurophysiological Features of Working Memory Performance and their Relationships with Demographic, Clinical, Genetic, Neurochemical, and Neuro-structural Characteristics in Older Adults at Risk for Dementia. University of Toronto (Canada); 2021.
  401. Peng C, Chen H, Li Y, Yang H, Qin P, Ma B, Duan Q, Wang B, Mao F, Guo D: LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma. Frontiers in oncology 2021, 11:54.
  402. Peretti DE, Renken RJ, Reesink FE, de Jong BM, De Deyn PP, Dierckx RA, Doorduin J, Boellaard R, García DV: Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis. NeuroImage: Clinical 2021, 30:102625.
  403. Peters S, Hofferber R, Privé BM, de Bakker M, Gotthardt M, Janssen M, de Lange F, Muselaers CH, Mehra N, Witjes JA: [68Ga] Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu] Lu-PSMA-617 treatment. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-12.
  404. Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Pfister J, Mair C, Novy Z, Popper M, Hajduch M: 68 Ga-labelled desferrioxamine-B for bacterial infection imaging. European journal of nuclear medicine and molecular imaging 2021, 48(2):372-382.
  405. Pfister J, Petrik M, Bendova K, Matuszczak B, Binder U, Kühbacher A, Gsaller F, Misslinger M, Haas H, Decristoforo C: Antifungal siderophore conjugates for theranostic applications in invasive pulmonary aspergillosis using low molecular TAFC scaffolds. bioRxiv 2021.
  406. Philippe C, Klebermass EM, Balber T, Kulterer OC, Zeilinger M, Egger G, Dumanic M, Herz CT, Kiefer FW, Scheuba C: Discovery of melanin‐concentrating hormone receptor 1 in brown adipose tissue. Annals of the New York Academy of Sciences 2021, 1494(1):70-86.
  407. Pierling AL, Elmenhorst E-M, Lange D, Hennecke E, Baur DM, Beer S, Kroll T, Neumaier B, Aeschbach D, Bauer A: Cerebral A1 adenosine receptor availability in female and male participants and its relationship to sleep. NeuroImage 2021, 245:118695.
  408. Pintado‐Berninches L, Montes‐Worboys A, Manguan‐García C, Arias‐Salgado EG, Serrano A, Fernandez‐Varas B, Guerrero‐López R, Iarriccio L, Planas L, Guenechea G: GSE4‐loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage. The FASEB Journal 2021, 35(3):e21422.
  409. Piron S, Verhoeven J, De Coster E, Descamps B, Kersemans K, Pieters L, Vral A, Vanhove C, De Vos F: Impact of the molar activity and PSMA expression level on [18F] AlF-PSMA-11 uptake in prostate cancer. Scientific reports 2021, 11(1):1-10.
  410. Polyak A, Bankstahl JP, Besecke KF, Hozsa C, Triebert W, Pannem RR, Manstein F, Borcholte T, Furch M, Zweigerdt R: Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells. Pharmaceutics 2021, 13(7):1097.
  411. Pozzi NG, Brumberg J, Todisco M, Minafra B, Zangaglia R, Bossert I, Trifirò G, Ceravolo R, Vitali P, Isaias IU: Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Movement Disorders 2021, 36(1):124-132.
  412. Prieto E, García-Velloso MJ, Aquerreta JD, Rosales JJ, Bastidas JF, Soriano I, Irazola L, Rodríguez-Otero P, Quincoces G, Martí-Climent JM: Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma. Physica Medica 2021, 84:1-9.
  413. Proesmans S, Raedt R, Germonpré C, Christiaen E, Descamps B, Boon P, De Herdt V, Vanhove C: Voxel-based analysis of [18F]-FDG brain PET in rats using data-driven normalization. Frontiers in Medicine 2021, 8.
  414. Puig O, Henriksen OM, Andersen FL, Lindberg U, Højgaard L, Law I, Ladefoged CN: Deep-learning-based attenuation correction in dynamic [15O] H2O studies using PET/MRI in healthy volunteers. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211029178.
  415. Pulagam KR, Henriksen-Lacey M, B. Uribe K, Renero-Lecuna C, Kumar J, Charalampopoulou A, Facoetti A, Protti N, Gómez-Vallejo V, Baz Z: In Vivo Evaluation of Multifunctional Gold Nanorods for Boron Neutron Capture and Photothermal Therapies. ACS Applied Materials & Interfaces 2021, 13(42):49589-49601.
  416. Qian Y, Liu Q, Li P, Han Y, Zhang J, Xu J, Sun J, Wu A, Song S, Lu W: Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization. ACS nano 2021, 15(2):2933-2946.
  417. Raffel DM, Crawford TC, Jung Y-W, Koeppe RA, Gu G, Rothley J, Frey KA: Quantifying Cardiac Sympathetic Denervation: First Studies of 18F-Fluorohydroxyphenethylguanidines in Cardiomyopathy Patients. 2021.
  418. Rahman FU, Kim Y-R, Kim E-K, Kim H-r, Cho S-M, Lee C-S, Kim SJ, Araki K, Yamamura K-i, Lee M-N: Topoisomerase IIIβ Deficiency Induces Neuro-Behavioral Changes and Brain Connectivity Alterations in Mice. International Journal of Molecular Sciences 2021, 22(23):12806.
  419. Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, Knoop H, Klein H, Bleeker-Rovers C, Doorduin J: No signs of neuroinflammation in women with chronic fatigue syndrome or Q fever fatigue syndrome using the TSPO ligand [11C]-PK11195. Neurology-Neuroimmunology Neuroinflammation 2022, 9(1).
  420. Ramakrishnan NK, Hird M, Thompson S, Williamson DJ, Qiao L, Owen DR, Brooks AF, Scott PJ, Bacallado S, O’Brien JT: Preclinical evaluation of (S)-[18F] GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971. European Journal of Nuclear Medicine and Molecular Imaging 2021, 49(1):125-136.
  421. Raval NR, Gudmundsen F, Juhl M, Andersen IV, Speth N, Videbæk A, Petersen IN, Mikkelsen JD, Fisher PM, Herth MM: Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease. Frontiers in synaptic neuroscience 2021, 13.
  422. Rey-Bretal D, Moscoso A, Gómez-Lado N, Fernández-Ferreiro A, Silva-Rodríguez J, Ruibal Á, Aguiar P: Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats. Molecular Imaging and Biology 2021, 23(3):350-360.
  423. Reyes ST, Deacon RM, Guo SG, Castillo JB, van der Wildt B, Morales AP, Park JH, Klamer D, Rosenberg J, Oberman LM: Effects of the Sigma-1 Receptor Agonist Blarcamesine in a Murine Model of Fragile X Syndrome: Neurobehavioral Phenotypes and Receptor Occupancy. 2021.
  424. Rischka L, Vraka C, Pichler V, Rasul S, Nics L, Gryglewski G, Handschuh P, Murgas M, Godbersen G, Silberbauer L: First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1. Journal of Nuclear Medicine 2021.
  425. Rocha NP, Charron O, Latham LB, Colpo GD, Zanotti-Fregonara P, Yu M, Freeman L, Stimming EF, Teixeira AL: Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology. Neurology-Neuroimmunology Neuroinflammation 2021, 8(3).
  426. Röhrich M, Leitz D, Glatting FM, Wefers AK, Weinheimer O, Flechsig P, Kahn N, Mall MA, Giesel FL, Kratochwil C: Fibroblast Activation Protein specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. Journal of nuclear medicine 2021.
  427. Ros T, Kwiek J, Andriot T, Michela A, Vuilleumier P, Garibotto V, Ginovart N: PET imaging of dopamine neurotransmission during EEG neurofeedback. Frontiers in Physiology 2021:1749.
  428. Rosar F, Bohnenberger H, Moon ES, Rösch F, Denig A, Vincenz-Zörner D, Hoffmann MA, Khreish F, Ezziddin S, Schreckenberger M: Impact of prompt gamma emission of 44Sc on quantification in preclinical and clinical PET systems. Applied Radiation and Isotopes 2021, 170:109599.
  429. Rosen J, Stoffels G, Lohmann P, Bauer EK, Werner JM, Wollring M, Rapp M, Felsberg J, Kocher M, Fink G: Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement. 2021.
  430. Rosestedt M, Velikyan I, Rosenström U, Estrada S, Åberg O, Weis J, Westerlund C, Ingvast S, Korsgren O, Nordeman P: Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1. Nuclear Medicine and Biology 2021, 93:54-62.
  431. Rowe CC, Krishnadas N, Ackermann U, Doré V, Goh RY, Guzman R, Chong L, Bozinovski S, Mulligan R, Kanaan R: PET Imaging of brain muscarinic receptors with 18F-Fluorobenzyl-Dexetimide: A first in human study. Psychiatry Research: Neuroimaging 2021, 316:111354.
  432. Rühling S: Neurodegeneration in multiple sclerosis mouse models. lmu; 2021.
  433. Rühlmann C, Dannehl D, Brodtrück M, Adams AC, Stenzel J, Lindner T, Krause BJ, Vollmar B, Kuhla A: Neuroprotective Effects of the FGF21 Analogue LY2405319. Journal of Alzheimer’s Disease 2021(Preprint):1-13.
  434. Ruze R, Xu Q, Liu G, Li Y, Chen W, Cheng Z, Xiong Y, Liu S, Zhang G, Hu S: Central GLP-1 contributes to improved cognitive function and brain glucose uptake after duodenum-jejunum bypass on obese and diabetic rats. American Journal of Physiology-Endocrinology and Metabolism 2021, 321(3):E392-E409.
  435. Sachpekidis C, Hassel JC, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A: Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors. Cancers 2021, 13(5):1019.
  436. Sachpekidis C, Merz M, Raab M-S, Bertsch U, Weru V, Kopp-Schneider A, Jauch A, Goldschmidt H, Dimitrakopoulou-Strauss A: The prognostic significance of [18F] FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs). EJNMMI research 2021, 11(1):1-12.
  437. Sakayori T, Tateno A, Arakawa R, Kim W-c, Okubo Y: Evaluation of dopamine D 3 receptor occupancy by blonanserin using [11 C]-(+)-PHNO in schizophrenia patients. Psychopharmacology 2021, 238(5):1343-1350.
  438. Salmon E, Bahri MA, Plenevaux A, Becker G, Seret A, Delhaye E, Degueldre C, Balteau E, Lemaire C, Luxen A: In vivo exploration of synaptic projections in frontotemporal dementia. Scientific reports 2021, 11(1):1-10.
  439. Sanaat A, Mirsadeghi E, Razeghi B, Ginovart N, Zaidi H: Fast Dynamic Brain PET Imaging Using Stochastic Variational Prediction for Recurrent Frame Generation. Medical physics 2021.
  440. Sanaat A, Shooli H, Ferdowsi S, Shiri I, Arabi H, Zaidi H: DeepTOFSino: A deep learning model for synthesizing full-dose time-of-flight bin sinograms from their corresponding low-dose sinograms. NeuroImage 2021, 245:118697.
  441. Sanches E, Dos Santos T, Odorcyk F, Untertriefallner H, Rezena E, Hoeper E, Avila T, Martini A, Venturin G, da Costa JC: Pregnancy swimming prevents early brain mitochondrial dysfunction and causes sex-related long-term neuroprotection following neonatal hypoxia-ischemia in rats. Experimental Neurology 2021, 339:113623.
  442. Sandahl TD, Gormsen LC, Kjærgaard K, Vendelbo MH, Munk DE, Munk OL, Bender D, Keiding S, Vase KH, Frisch K: The pathophysiology of Wilson disease visualised: A human 64Cu PET study. Hepatology 2021.
  443. Sandbhor P, Goda J, Mohanty B, Chaudhari P, Dutt S, Banerjee R: Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models. Nanoscale 2021.
  444. Sander CY, Bovo S, Torrado-Carvajal A, Albrecht D, Deng H, Napadow V, Price JC, Hooker JM, Loggia ML: [11C] PBR28 radiotracer kinetics are not driven by alterations in cerebral blood flow. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211023387.
  445. Sari H, Hong J, Eriksson L, Shi K, Conti M, Alberts I, Cumming P, Rominger A: Kinetic modelling of dynamic 18F-FDG datasets from long axial field-of-view PET scanner. In.: Soc Nuclear Med; 2021.
  446. Sato H, Takado Y, Toyoda S, Tsukamoto-Yasui M, Minatohara K, Takuwa H, Urushihata T, Takahashi M, Shimojo M, Ono M: Neurodegenerative processes accelerated by protein malnutrition and decelerated by essential amino acids in a tauopathy mouse model. Science advances 2021, 7(43):eabd5046.
  447. Sato T, Furuta T, Liu Y, Naka S, Nagamori S, Kanai Y, Watabe T: Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model. EJNMMI physics 2021, 8(1):1-16.
  448. Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B, Nics L, Philippe C, Pfaff S, Pichler V: Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical 2021, 32:102813.
  449. Schadt F, Israel I, Samnick S: Development and validation of a semi-automated, preclinical, MRI-template based PET image data analysis tool for rodents. Frontiers in Neuroinformatics 2021, 15.
  450. Schaffernicht G, Shang Q, Stievenard A, Bötzel K, Dening Y, Kempe R, Toussaint M, Gündel D, Kranz M, Reichmann H: Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson’s Disease. Frontiers in neurology 2021, 12:363.
  451. Schaner PE, Tran L-B-A, Zaki BI, Swartz HM, Demidenko E, Williams BB, Siegel A, Kuppusamy P, Flood AB, Gallez B: The impact of particulate electron paramagnetic resonance oxygen sensors on fluorodeoxyglucose imaging characteristics detected via positron emission tomography. Scientific reports 2021, 11(1):1-8.
  452. Schmitt J, Palleis C, Sauerbeck J, Unterrainer M, Harris S, Prix C, Weidinger E, Katzdobler S, Wagemann O, Danek A: Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome. Frontiers in aging neuroscience 2021, 13:214.
  453. Schmitz F, Silveira JS, Venturin GT, Greggio S, Peixoto G, Zimmer E, Costa J, Wyse A: Evidence that methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks. 2021.
  454. Scott N, Teoh E, Flight H, Jones B, Niederer J, Mustata L, MacLean G, Roy P, Remoundos D, Snell C: Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging. British journal of cancer 2021:1-8.
  455. Sébastien G, Martine G, Becker G, Mylène G, Yann B, André L, Lemaire C, Alain P, Salmon E, Philippe H: The pharmacokinetics of [18 F] UCB-H revisited in the healthy non-human primate brain. EJNMMI Research 2021, 11(1).
  456. Sekar S, Viswas RS, Miranzadeh Mahabadi H, Alizadeh E, Fonge H, Taghibiglou C: Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study. International journal of molecular sciences 2021, 22(16):9005.
  457. Senda M, Ishii K, Ito K, Ikeuchi T, Matsuda H, Iwatsubo T, Iwata A, Ihara R, Suzuki K, Kasuga K: A Japanese multicenter study on PET and other biomarkers for subjects with potential preclinical and prodromal Alzheimer’s disease. The Journal of Prevention of Alzheimer’s Disease 2021:1-8.
  458. Shanbhag S, Suliman S, Mohamed-Ahmed S, Kampleitner C, Hassan MN, Heimel P, Dobsak T, Tangl S, Bolstad AI, Mustafa K: Bone regeneration in rat calvarial defects using dissociated or spheroid mesenchymal stromal cells in scaffold-hydrogel constructs. Stem cell research & therapy 2021, 12(1):1-17.
  459. Sharda N, Ahlschwede KM, Curran GL, Lowe VJ, Kandimalla KK: Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endothelium. Journal of Pharmacology and Experimental Therapeutics 2021, 376(3):482-490.
  460. Sheybani ND, Breza VR, Paul S, McCauley KS, Berr SS, Miller GW, Neumann KD, Price RJ: ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma. Journal of Controlled Release 2021, 331:19-29.
  461. Shidahara M, Funaki Y, Watabe H: Noninvasive estimation of human radiation dosimetry of 18F-FDG by whole-body small animal PET imaging in rats. Applied Radiation and Isotopes 2021:110071.
  462. Shimojo M, Ono M, Takuwa H, Mimura K, Nagai Y, Fujinaga M, Kikuchi T, Okada M, Seki C, Tokunaga M: A genetically targeted reporter for PET imaging of deep neuronal circuits in mammalian brains. The EMBO journal 2021, 40(22):e107757.
  463. Shin S, Nam H-Y, Lee MJ, Pak K, Kim K, Kim IJ: Effect of sex on aging-related decline of dopamine transporter in healthy subjects. Annals of Nuclear Medicine 2021, 35(1):76-82.
  464. Shinotoh H, Hirano S, Shimada H: PET imaging of acetylcholinesterase. In: PET and SPECT of Neurobiological Systems. edn.: Springer, Cham; 2021: 193-220.
  465. Shokri-Kojori E, Wang G-J, Volkow ND: Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men. Translational psychiatry 2021, 11(1):1-7.
  466. Shrestha UM, Sciammarella M, Pampaloni MH, Botvinick EH, Gullberg GT, DeMarco T, Seo Y: Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82 Rb PET. The International Journal of Cardiovascular Imaging 2021, 37(4):1461-1472.
  467. Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T: Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET. Molecular psychiatry 2021, 26(3):1009-1018.
  468. Sinharay S, Srinivasula S, Schreiber-Stainthorp W, Shah S, Degrange P, Bonvillain A, Wang J, Dodd L, Carrasquillo JA, Hammoud DA: Monitoring Immune Activation with Whole-Body Fluorodeoxyglucose–Positron-Emission Tomography in Simian Immunodeficiency Virus–Infected Rhesus Macaques. ImmunoHorizons 2021, 5(7):557-567.
  470. Smigielski L, Wotruba D, Treyer V, Rössler J, Papiol S, Falkai P, Grünblatt E, Walitza S, Rössler W: The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study. Schizophrenia Bulletin 2021.
  471. Soeder JM, Luthardt J, Rullmann M, Becker GA, Hankir MK, Patt M, Meyer PM, Schütz T, Ding Y-S, Hilbert A: Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity. Obesity Surgery 2021, 31(11):4868-4876.
  472. Sohara K, Sekine T, Tateno A, Mizumura S, Suda M, Sakayori T, Okubo Y, Kumita S-i: Multi-Atlas MRI-Based Striatum Segmentation for 123I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson’s Disease/Syndrome. Frontiers in Medicine 2021, 8.
  473. Son HJ, Oh JS, Oh M, Lee SJ, Oh SJ, Chung SJ, Kim JS: Test–retest reproducibility of dopamine transporter density measured with [18 F] FP-CIT PET in patients with essential tremor and Parkinson’s disease. Annals of Nuclear Medicine 2021, 35(3):299-306.
  474. Song AK, Hay KR, Trujillo P, Aumann M, Stark AJ, Yan Y, Kang H, Donahue MJ, Zald DH, Claassen DO: Amphetamine-induced dopamine release and impulsivity in Parkinson disease. Brain 2021.
  475. Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K, Nitschmann A, Scheifele M, Palleis C, Respondek G: Binding characteristics of [18F] PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211018904.
  476. Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K, Eckenweber F, Palleis C, Kaiser L, Finze A: Feasibility of short imaging protocols for [18 F] PI-2620 tau-PET in progressive supranuclear palsy. European journal of nuclear medicine and molecular imaging 2021:1-14.
  477. Sørensen M, Fode MM, Petersen JB, Holt MI, Høyer M: Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F] FDGal PET/CT. Radiation Oncology 2021, 16(1):1-7.
  478. Sourdon J, Facchin C, Certain A, Viel T, Robin B, Lager F, Marchiol C, Balvay D, Yoganathan T, Favier J: Sunitinib-induced cardiac hypertrophy and the endothelin axis. Theranostics 2021, 11(8):3830.
  479. Spimpolo A, Lombardi G, Berti S, Campi C, Anglani MG, Simeone R, Evangelista L, Causin F, Zorzi G, Gorgoni G: Preliminary results using PET/MR in glioblastoma patients treated with regorafenib: an 18F-FET and DWI-ADC comparison. 2021.
  480. Staniszewska M, Fragoso Costa P, Eiber M, Klose JM, Wosniack J, Reis H, Szarvas T, Hadaschik B, Lückerath K, Herrmann K: Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. International journal of molecular sciences 2021, 22(14):7431.
  481. Stojakovic A, Chang S-Y, Nesbitt J, Pichurin NP, Ostroot MA, Aikawa T, Kanekiyo T, Trushina E: Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice. Journal of Alzheimer’s Disease 2021(Preprint):1-19.
  482. Stojakovic A, Trushin S, Sheu A, Khalili L, Chang S-Y, Li X, Christensen T, Salisbury JL, Geroux RE, Gateno B: Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice. Communications biology 2021, 4(1):1-20.
  483. Stormezand GN, Doorduin J, Chaves LT, García DV, Nienhuis FJ, Schoevers RA, Kremer BP, Booij J, Dierckx RA: No evidence for decreased D2/3 receptor availability and frontal hypoperfusion in subjects with compulsive pornography use. Psychiatry Research: Neuroimaging 2021, 311:111284.
  484. Stormezand GN, Doorduin J, Rakers SE, Spikman JM, van der Naalt J, García DV, van der Hoorn A, van der Weijden CW, Kremer BP, Renken RJ: Imaging of Neuroinflammation Due to Repetitive Head Injury in Currently Active Kickboxers. 2021.
  485. Streffer J, Treyer V, Buck A, Ametamey SM, Blagoev M, Maguire RP, Gautier A, Auberson YP, Schmidt ME, Vranesic I-T: Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers. NeuroImage 2021, 230:117785.
  486. Subramanian S, Daquinag AC, AghaAmiri S, Ghosh SC, Azhdarinia A, Kolonin MG: Characterization of peptides targeting metastatic tumor cells as probes for cancer detection and vehicles for therapy delivery. Cancer Research 2021, 81(22):5756-5764.
  487. Suchacki KJ, Alcaide-Corral CJ, Nimale S, Macaskill MG, Stimson RH, Farquharson C, Freeman TC, Tavares AA: A Systems-Level Analysis of Total-Body PET Data Reveals Complex Skeletal Metabolism Networks in vivo. Frontiers in Medicine 2021:1592.
  488. Sucunza D, Rico AJ, Roda E, Collantes M, González-Aseguinolaza G, Rodríguez-Pérez AI, Peñuelas I, Vázquez A, Labandeira-García JL, Broccoli V: Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques. International Journal of Molecular Sciences 2021, 22(9):4825.
  489. Sugita S, Yamato M, Hatabu T, Kataoka Y: Involvement of cancer-derived EMT cells in the accumulation of 18 F-fluorodeoxyglucose in the hypoxic cancer microenvironment. Scientific reports 2021, 11(1):1-11.
  490. Sukprakun C, Limotai C, Khamwan K, Pasawang P, Tepmongkol S: A Novel Method of Seizure Onset Zone Localization by Serial Tc-99m ECD Brain Perfusion SPECT Clearance Patterns. 2021.
  491. Sullivan KJ, Liu A, Chang C-CH, Cohen AD, Lopresti BJ, Minhas DS, Laymon CM, Klunk WE, Aizenstein H, Nadkarni NK: Alzheimer’s disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study. Brain imaging and behavior 2021, 15(3):1355-1363.
  492. Suurs FV, Lorenczewski G, Bailis JM, Stienen S, Friedrich M, Lee F, van der Vegt B, de Vries EG, de Groot D-JA, Lub-de Hooge MN: Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues. Journal of Nuclear Medicine 2021.
  493. Taddei C, Morse CL, Kim M-J, Liow J-S, Montero Santamaria J, Zhang A, Manly LS, Zanotti-Fregonara P, Gladding RL, Zoghbi SS: Synthesis of [18F] PS13 and Evaluation as a PET Radioligand for Cyclooxygenase-1 in Monkey. ACS Chemical Neuroscience 2021, 12(3):517-530.
  494. Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y: High-contrast in vivo imaging of tau pathologies in Alzheimer’s and non-Alzheimer’s disease tauopathies. Neuron 2021, 109(1):42-58. e48.
  495. Tago T, Toyohara J, Ishii K: Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain. ACS Chemical Neuroscience 2021, 12(4):746-755.
  496. Takahashi K, Hosoya T, Onoe K, Mori T, Tazawa S, Mawatari A, Wada Y, Watanabe Y, Watanabe Y: PET imaging of brain aromatase in humans and rhesus monkeys by 11C-labeled cetrozole analogs. Scientific reports 2021, 11(1):1-9.
  497. Takahata K, Seki C, Kimura Y, Kubota M, Ichise M, Sano Y, Yamamoto Y, Tagai K, Shimada H, Kitamura S: First-In-Human in Vivo Imaging and Quantification of Monoacylglycerol Lipase in The Brain: A PET Study With 18F-T-401. 2021.
  498. Takhsha FS, Vangestel C, Tanc M, De Bruycker S, Berg M, Pintelon I, Stroobants S, De Meyer GR, Van Der Veken P, Martinet W: ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2021, 11:750259-750259.
  499. Tamm S, Lensmar C, Andreasson A, Axelsson J, Morén AF, Grunewald J, Gyllfors P, Karshikoff B, Kosek E, Lampa J: Objective and Subjective Sleep in Rheumatoid Arthritis and Severe Seasonal Allergy: Preliminary Assessments of the Role of Sickness, Central and Peripheral Inflammation. Nature and Science of Sleep 2021, 13:775.
  500. Teodoro R, Gündel D, Deuther-Conrad W, Ueberham L, Toussaint M, Bormans G, Brust P, Moldovan R-P: Development of [18F] LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain. International Journal of Molecular Sciences 2021, 22(15):8051.
  501. Terada T, Therriault J, Kang MSP, Savard M, Pascoal TA, Lussier F, Tissot C, Wang Y-T, Benedet A, Matsudaira T: Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease. Molecular Neurodegeneration 2021, 16(1):1-12.
  502. Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, Suzuki N, Morimoto A, Nakahara T, Iwabuchi Y: Evaluation of [18F] PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies. Brain communications 2021, 3(4):fcab190.
  503. Thanos PK, Lamoshi A, Nubelo A, Hamilton J, Chernoguz A, Hoffman AB, Quattrin T, Harmon C: Clinical and Preclinical Bariatric Surgery Approaches to Studying Obesity. Animal Models of Eating Disorders 2021:187-201.
  504. Thomsen MB, Ferreira SA, Schacht AC, Jacobsen J, Simonsen M, Betzer C, Jensen PH, Brooks DJ, Landau AM, Romero-Ramos M: PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease 2021, 149:105229.
  505. Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C] UCB-J PET. Journal of Cerebral Blood Flow & Metabolism 2021, 41(4):819-830.
  506. Thorne M, Cash M, Reid G, Burley D, Luke D, Pottie I, Darvesh S: Imaging butyrylcholinesterase in multiple sclerosis. Molecular Imaging and Biology 2021, 23(1):127-138.
  507. Tien H-J, Yang H-C, Shueng P-W, Chen J-C: Cone-beam CT image quality improvement using Cycle-Deblur consistent adversarial networks (Cycle-Deblur GAN) for chest CT imaging in breast cancer patients. Scientific Reports 2021, 11(1):1-12.
  508. Tiepolt S, Becker G-A, Wilke S, Cecchin D, Rullmann M, Meyer PM, Barthel H, Hesse S, Patt M, Luthardt J: (+)-[18 F] Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls. European journal of nuclear medicine and molecular imaging 2021, 48(3):731-746.
  509. Tjörnstrand A, Casar‐Borota O, Heurling K, Schöll M, Gjertsson P, Ragnarsson O, Filipsson Nyström H: Pre‐and postoperative 68Ga‐DOTATOC positron emission tomography for hormone‐secreting pituitary neuroendocrine tumours. Clinical Endocrinology 2021, 94(6):956-967.
  510. Todisco M, Zangaglia R, Minafra B, Pisano P, Trifirò G, Bossert I, Pozzi NG, Brumberg J, Ceravolo R, Isaias IU: Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus. Neurology 2021, 96(23):e2861-e2873.
  511. Tournier N, Goutal S, Mairinger S, Hernández-Lozano I, Filip T, Sauberer M, Caillé F, Breuil L, Stanek J, Freeman AF: Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C] erlotinib. Journal of Cerebral Blood Flow & Metabolism 2021, 41(7):1634-1646.
  512. Tournier N, Pottier G, Caillé F, Coulon C, Goislard M, Jégo B, Negroni J, Leroy C, Saba W: Nalmefene alleviates the neuroimmune response to repeated binge‐like ethanol exposure: A TSPO PET imaging study in adolescent rats. Addiction Biology 2021, 26(3):e12962.
  513. Toyohara J, Sakata M, Ishibashi K, Mossel P, Imai M, Wagatsuma K, Tago T, Imabayashi E, Colabufo NA, Luurtsema G: First clinical assessment of [18F] MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood–brain barrier. Annals of nuclear medicine 2021, 35(11):1240-1252.
  514. Treyer V, Meyer RS, Buchmann A, Crameri GA, Studer S, Saake A, Gruber E, Unschuld PG, Nitsch RM, Hock C: Physical activity is associated with lower cerebral beta-amyloid and cognitive function benefits from lifetime experience–a study in exceptional aging. PloS one 2021, 16(2):e0247225.
  515. Truong VA, Lin Y-H, Nguyen NTK, Hsu M-N, Pham NN, Chang Y-H, Chang C-W, Shen C-C, Lee H-S, Lai P-L: Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats. Molecular Therapy 2021.
  516. Tsubaki Y, Kitamura T, Shimokawa N, Akamatsu G, Sasaki M: Improved accuracy of amyloid PET quantification with adaptive template-based anatomical standardization. Journal of Nuclear Medicine Technology 2021.
  517. Turnock S: PET imaging to monitor NET-1 and GD2 expression in neuroblastoma. 2021.
  518. Tyan Y-S, Lee Y-P, Chuang H-Y, Wang W-H, Hwang J-J: Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model. Bioscience reports 2021, 41(5):BSR20204203.
  519. Valli M, Cho SS, Masellis M, Chen R, Koshimori Y, Diez‐Cirarda M, Mihaescu A, Christopher L, Strafella AP: Extra‐striatal dopamine in Parkinson’s disease with rapid eye movement sleep behavior disorder. Journal of Neuroscience Research 2021, 99(4):1177-1187.
  520. van Aalst J, Ceccarini J, Sunaert S, Dupont P, Koole M, Van Laere K: In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X20981502.
  521. van Aalst J, Devrome M, Van Weehaeghe D, Rezaei A, Radwan A, Schramm G, Ceccarini J, Sunaert S, Koole M, Van Laere K: Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-17.
  522. Van Der Heiden K, Barrett H, Meester E, van Gaalen K, Krenning B, Beekman F, de Blois E, de Swart J, Verhagen H, van der Lugt A: SPECT/CT imaging of inflammation and calcification in human carotid atherosclerosis to identify the plaque at risk of rupture. Journal of Nuclear Cardiology 2021:1-10.
  523. van der Weijden MC, Rodriguez‐Contreras D, Delnooz CC, Robinson BG, Condon AF, Kielhold ML, Stormezand GN, Ma KY, Dufke C, Williams JT: A gain‐of‐function variant in dopamine D2 receptor and progressive chorea and dystonia phenotype. Movement Disorders 2021, 36(3):729-739.
  524. van der Wildt B, Miao Z, Reyes ST, Park JH, Klockow JL, Zhao N, Romero A, Guo SG, Shen B, Windhorst AD: BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain. Nuclear Medicine and Biology 2021.
  525. van Dijken BR, Schuuring B, Jeltema H-R, van Laar PJ, Enting RH, Dierckx RA, Stormezand GN, van Der Hoorn A: Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma. Neuroradiology 2021:1-6.
  526. van Ton AMP, Duindam HB, van Tuijl J, Li WW, Dieker H-J, Riksen NP, Meijer FA, Kessels RP, Kohn N, van der Hoeven JG: Neuroinflammation in cognitive decline post-cardiac surgery (the FOCUS study): an observational study protocol. BMJ open 2021, 11(5):e044062.
  527. van Ton AMP, Leijte GP, Franssen GM, Bruse N, Booij J, Doorduin J, Rijpkema M, Kox M, Abdo WF, Pickkers P: Human in vivo neuroimaging to detect reprogramming of the cerebral immune response following repeated systemic inflammation. Brain, Behavior, and Immunity 2021, 95:321-329.
  528. van Wolfswinkel E, Wielaard J, Lavalaye J, Hoff J, Habraken J: Artificial Intelligence-Based Assistance in Clinical 123I-FP-CIT SPECT Scan Interpretation. 2021.
  529. Varela LG, García DV, Aguiar P, Kakiuchi T, Ohba H, Harada N, Nishiyama S, Tago T, Elsinga PH, Tsukada H: Head to head comparison of (R)-[11C] verapamil and [18F] MC225 in non-human primates, tracers for measuring P-glycoprotein function. 2021.
  530. Varnäs K, Finnema SJ, Johnström P, Arakawa R, Halldin C, Eriksson LI, Farde L: Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B in vivo. British Journal of Anaesthesia 2021, 126(1):238-244.
  531. Veal M, Dias G, Kersemans V, Sneddon D, Faulkner S, Cornelissen B: A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes. Journal of Nuclear Medicine 2021.
  532. Velikyan I, Rosenström U, Rosestedt M, Eriksson O, Antoni G: Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of Fibrosis. Pharmaceuticals 2021, 14(10):990.
  533. Vera JH, Eftychiou N, Schuerer M, Rullmann M, Barthel H, Sabri O, Gisslen M, Zetterberg H, Blennow K, O’Brien C: Clinical Utility of β-Amyloid PET Imaging in People Living With HIV With Cognitive Symptoms. JAIDS Journal of Acquired Immune Deficiency Syndromes 2021, 87(2):826-833.
  534. Vermeulen K, Cools R, Briard E, Auberson Y, Schoepfer J, Koole M, Cawthorne C, Bormans G: Preclinical Evaluation of [11C] YC-72-AB85 for In Vivo Visualization of Heat Shock Protein 90 in Brain and Cancer with Positron Emission Tomography. ACS Chemical Neuroscience 2021, 12(20):3915-3927.
  535. Vestergaard MB, Calvo OP, Hansen AE, Rosenbaum S, Larsson HB, Henriksen OM, Law I: Validation of kinetic modeling of [15O] H2O PET using an image derived input function on hybrid PET/MRI. NeuroImage 2021, 233:117950.
  536. Viswanath V, Zhou R, Lee H, Li S, Cragin A, Doot RK, Mankoff DA, Pantel AR: Kinetic modeling of 18F-(2S, 4R) 4-fluoroglutamine in mouse models of breast cancer to estimate glutamine pool size as an indicator of tumor glutamine metabolism. Journal of Nuclear Medicine 2021, 62(8):1154-1162.
  537. Völter F, Mittlmeier L, Gosewisch A, Brosch-Lenz J, Gildehaus FJ, Zacherl MJ, Beyer L, Stief CG, Holzgreve A, Rübenthaler J: Correlation of An Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy. Diagnostics 2021, 11(3):428.
  538. von Felten E, Benz DC, Benetos G, Baehler J, Patriki D, Rampidis GP, Giannopoulos AA, Bakula A, Gräni C, Pazhenkottil AP: Prognostic value of regional myocardial flow reserve derived from 13N-ammonia positron emission tomography in patients with suspected coronary artery disease. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-10.
  539. Vrist M, Bech J, Lauridsen T, Fynbo C, Theil J: Comparison of [18F] NaF PET/CT dynamic analysis methods and a static analysis method including derivation of a semi-population input function for site-specific measurements of bone formation in a population with chronic kidney disease-mineral and bone disorder. EJNMMI research 2021, 11(1):1-13.
  540. Wagner JM, Sichler ME, Schleicher EM, Franke TN, Irwin C, Löw MJ, Beindorff N, Bouter C, Bayer TA, Bouter Y: Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s. Frontiers in Behavioral Neuroscience-Editor’s Pick 2021 2021.
  541. Wakabayashi T, Hirose Y, Miyake K, Arakawa Y, Kagawa N, Nariai T, Narita Y, Nishikawa R, Tsuyuguchi N, Fukami T: Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials. Annals of Nuclear Medicine 2021, 35(12):1279-1292.
  542. Wang C, Zhou C, Guo T, Huang P, Xu X, Zhang M: Neural Substrates for the Association Between Cigarette Smoking and Parkinson’s Disease. 2021.
  543. Wang H, Zhao Q, Dong W, Yang L, Lu K, Guo X, Liu H, Wei H, Cheng Y, Wu Z: Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging. Nuclear Medicine and Biology 2021, 94:98-105.
  544. Wang SJ, Lee C-H, Kang HG, Kim KW, Kim M, Jeong H-J, Shin B-S: Peripheral vasoreactivity in acute ischemic stroke with hemiplegia. Scientific reports 2021, 11(1):1-7.
  545. Wang Y, Cai L, Zhou K, Cui M, Yao S: Biodistribution and Dosimetry Evaluation for A Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease. 2021.
  546. Wang Y, Lou F, Li Y, Liu F, Wang Y, Cai L, Gordon ML, Zhang Y, Zhang N: Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid-positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer’s Disease and Amnestic Mild Cognitive Impairment. Current Alzheimer Research 2021.
  547. Wang Z, Manion MM, Laidlaw E, Rupert A, Lau C-Y, Smith BR, Nath A, Sereti I, Hammoud DA: Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation. AIDS 2021, 35(8):1209-1219.
  548. Willuweit A, Schöneck M, Schemmert S, Lohmann P, Bremen S, Honold D, Burda N, Jiang N, Beer S, Ermert J: Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography. Frontiers in neuroscience 2021:1248.
  549. Wong SW, Vivash L, Mudududdla R, Nguyen N, Hermans SJ, Shackleford DM, Field J, Xue L, Aprico A, Hancock NC: Development of [18F] MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease. European Journal of Medicinal Chemistry 2021, 226:113822.
  550. Wu C-Y, Lin Y-H, Hsieh H-H, Lin J-J, Peng S-L: Sex Differences in the Effect of Diabetes on Cerebral Glucose Metabolism. Biomedicines 2021, 9(11):1661.
  551. Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A: Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Science Translational Medicine 2021, 13(615):eabe5640.
  552. Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S: In vivo imaging of synaptic density with [11C] UCB-J PET in two mouse models of neurodegenerative disease. NeuroImage 2021:118302.
  553. Xu Q, Ding H, Li S, Dong S, Li L, Shi B, Zhong M, Zhang G: Sleeve Gastrectomy Ameliorates Diabetes-Induced Cardiac Hypertrophy Correlates With the MAPK Signaling Pathway. Frontiers in physiology 2021:2037.
  554. Xu Y, Chen Z, Wey HY, Liang Y, Tanzi RE, Zhang C, Wang C: Molecular imaging of NAD+‐dependent deacetylase SIRT1 in the brain. Alzheimer’s & Dementia 2021.
  555. Xu Y, Xu Y, Biby S, Bai P, Liu Y, Zhang C, Wang C, Zhang S: Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I. ACS chemical neuroscience 2021.
  556. Yakushev I, Ripp I, Wang M, Savio A, Schutte M, Lizarraga A, Bogdanovic B, Diehl-Schmid J, Hedderich DM, Grimmer T: Mapping covariance in brain FDG uptake to structural connectivity. European journal of nuclear medicine and molecular imaging 2021:1-10.
  557. Yamagishi S, Iga Y, Ikegaya S, Kakiuchi T, Ohba H, Nishiyama S, Fukomoto D, Kanazawa M, Harada N, Tsukada H: In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study. Journal of neuroinflammation 2021, 18(1):1-15.
  558. Yamamoto Y, Takahata K, Kubota M, Takano H, Takeuchi H, Kimura Y, Sano Y, Kurose S, Ito H, Mimura M: Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain. NeuroImage 2021, 226:117543.
  559. Yan S, Zheng C, Paranjpe MD, Li Y, Li W, Wang X, Benzinger TL, Lu J, Zhou Y, Initiative AsDN: Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals. Brain 2021.
  560. Yan X, Telu S, Dick RM, Liow J-S, Zanotti-Fregonara P, Morse CL, Manly LS, Gladding RL, Shrestha S, Lerchner W: [11C] deschloroclozapine is an improved PET radioligand for quantifying a human muscarinic DREADD expressed in monkey brain. Journal of Cerebral Blood Flow & Metabolism 2021:0271678X211007949.
  561. Yan Z, Li Y, Zhang X, Li L, Gao Y, Chen Q, Tian M, Cong B: PET neuroimaging reveals upregulation of dopamine D2 receptor contributes to amygdaloid dysfunction in rat acute restraint stress model. Biochemical and Biophysical Research Communications 2021, 561:45-51.
  562. Yang K-C, Liu M-N, Liou Y-J, Hu L-Y, Yang B-H, Chou Y-H: Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study. Journal of Psychiatric Research 2021, 135:174-180.
  563. Yang K-C, Yang B-H, Lirng J-F, Liu M-N, Hu L-Y, Liou Y-J, Chan L-A, Chou Y-H: Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study. Neurotoxicology 2021, 82:26-34.
  564. Yang X, Ignozzi AJ, He R, Zhu D, Wang X, Chordia MD, Pan D, Cui Q: Detection of Osteoarthritis Inflammation by Single-Photon Emission Computed Tomography Based on an Inflammation-Targeting Peptide cFLFLF. Molecular Imaging and Biology 2021:1-10.
  565. Yeh CI, Cheng MF, Xiao F, Chen YC, Liu CC, Chen HY, Yen RF, Ju YT, Chen Y, Bodduluri M: Effects of Focal Radiation on [18F]‐Fluoro‐D‐Glucose Positron Emission Tomography in the Brains of Miniature Pigs: Preliminary Findings on Local Metabolism. Neuromodulation: Technology at the Neural Interface 2021, 24(5):863-869.
  566. Yeh SH-H, Chang W-C, Hsu S-M, Lin MH, Chung M-C, Ke C-S, Lee Y-C, Hwang C-J, Yang DJ: Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors. Cancer Biotherapy and Radiopharmaceuticals 2021.
  567. Yeh SH-H, Chiu C-H, Kuo Y-Y, Tsai C-J, Yu T-H, Huang W-S, Ma K-H: Amitriptyline Accelerates SERT Binding Recovery Rate in MDMA-Induced Rat Model: In Vivo 4-[18F]-ADAM PET Imaging. 2021.
  568. Yeh SH-H, Huang W-S, Chiu C-H, Chen C-L, Chen H-T, Chi DY, Ge Z, Yu T-H, Wang P-Y, Kuo Y-Y: Automated Synthesis and Initial Evaluation of (4-Amino-5, 8-difluoro-1H-spiro [piperidine-4, 2-quinazolin]-1-yl)(4-[18F] fluorophenyl) methanone for PET/MR Imaging of Inducible Nitric Oxide Synthase. Molecular Imaging 2021, 2021.
  569. Yeh SH-H, Lin MH, Leo Garcia Flores I, Mukhopadhyay U, Young D, Ogawa K, Jeong J-H, Tong W, Gelovani JG, Fukumitsu N: In Vivo Evaluation of the Combined Anticancer Effects of Cisplatin and SAHA in Nonsmall Cell Lung Carcinoma Using [18F] FAHA and [18F] FDG PET/CT Imaging. Molecular imaging 2021, 2021.
  570. Yin L, Wang A, Shi H, Gao M: Quantitatively visualizing the activity of MMP-2 enzyme in vivo using a ratiometric photoacoustic probe. Methods in enzymology 2021, 657:59-87.
  571. Yokokura M, Takebasashi K, Takao A, Nakaizumi K, Yoshikawa E, Futatsubashi M, Suzuki K, Nakamura K, Yamasue H, Ouchi Y: In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study. Molecular Psychiatry 2021, 26(9):4958-4967.
  572. Yoon H-J, Kim BS, Jeong JH, Kim GH, Park HK, Chun MY: Asymmetric Amyloid Deposition as an Early Sign of Progression in Mild Cognitive Impairment Due to Alzheimer Disease. Clinical Nuclear Medicine 2021, 46(7):527-531.
  573. Yoon H-J, Kim BS, Jeong JH, Kim GH, Park HK, Chun MY, Ha S: Dual-phase 18F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer’s disease. NeuroImage: Clinical 2021, 31:102773.
  574. Young AJ, Pantel AR, Viswanath V, Dominguez TL, Makvandi M, Lee H, Li S, Schubert EK, Pryma DA, Farwell MD: Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer. Journal of Nuclear Medicine 2021.
  575. Yousefi-Koma A, Haseli S, Bakhshayeshkaram M, Raad N, Karimi-Galougahi M: Multimodality imaging with PET/CT and MRI reveals hypometabolism in tertiary olfactory cortex in parosmia of COVID-19. Academic Radiology 2021.
  576. Yuan G, Dhaynaut M, Guehl NJ, Afshar S, Huynh D, Moon S-H, Iyengar S, Kang HJ, Ondrechen MJ, El Fakhri G: Design, synthesis, and characterization of [18F] mG2P026 as a high contrast PET imaging ligand for metabotropic glutamate receptor 2. bioRxiv 2021.
  577. Yuan G, Dhaynaut M, Guehl NJ, Neelamegam R, Moon S-H, Qu X, Poutiainen P, Afshar S, El Fakhri G, Brownell A-L: PET imaging studies to investigate functional expression of mGluR2 using [11C] mG2P001. bioRxiv 2021.
  578. Yuan G, Dhaynaut M, Lan Y, Guehl NJ, Huynh D, Iyengar S, Afshar S, Wang H, Moon S-H, Ondrechen MJ: Synthesis and characterization of 5-(2-fluoro-4-[11C] methoxyphenyl)-2, 2-dimethyl-3, 4-dihydro-2H-pyrano [2, 3-b] pyridine-7-carboxamide as a PET imaging ligand for metabotropic glutamate receptor 2. bioRxiv 2021.
  579. Yuan G, Guehl NJ, Zheng B, Qu X, Moon S-H, Dhaynaut M, Shoup TM, Afshar S, Kang HJ, Zhang Z: Synthesis and Characterization of [18 F] JNJ-46356479 as the First 18 F-Labeled PET Imaging Ligand for Metabotropic Glutamate Receptor 2. Molecular Imaging and Biology 2021:1-10.
  580. Zangooei MH, Margolis R, Hoyt K: Multiscale computational modeling of cancer growth using features derived from microCT images. Scientific reports 2021, 11(1):1-17.
  581. Zanovello M, Sorarù G, Campi C, Anglani M, Spimpolo A, Berti S, Bussè C, Mozzetta S, Cagnin A, Cecchin D: Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a 18F-FDG PET/MR study. Journal of Nuclear Medicine 2021.
  582. Zerweck L, Roder C, Hauser T-K, Thurow J, Mengel A, Tatagiba M, Khan N, Meyer PT, Ernemann U, Klose U: Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O] water PET. Neuroradiology 2021:1-11.
  583. Zhang K, Mizuma H, Nakatani Y, Kanayama Y, Takahashi K, Matsumoto Y, Wada Y, Onoe K, Owada S, Hayashinaka E: Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studies. European journal of nuclear medicine and molecular imaging 2021:1-14.
  584. Zhao J, Chen S, Zhu L, Zhang L, Liu J, Xu D, Tian G, Jiang Ta: Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer. Frontiers in Oncology 2021, 10:3376.
  585. Zhao Z-H, Du K-J, Wang T, Wang J-Y, Cao Z-P, Chen X-M, Song H, Zheng G, Shen X-F: Maternal Lead Exposure Impairs Offspring Learning and Memory via Decreased GLUT4 Membrane Translocation. Frontiers in Cell and Developmental Biology 2021, 9:374.
  586. Zheng EW, Yu-Ju C, Wei-Ting C, Kuan-Yu W, Cheng-Yu T, Sin-Jhong C, Carter RN, Guo-Jen H: The effect of nerve growth factor on supporting spatial memory depends upon hippocampal cholinergic innervation. Translational Psychiatry 2021, 11(1).
  587. Zhong Y, Yang S, Cui J, Wang J, Li L, Chen Y, Chen J, Feng P, Huang S, Li H: Novel 18F-Labeled Isonicotinamide-Based Radioligands for Positron Emission Tomography Imaging of Glycogen Synthase Kinase-3β. Molecular Pharmaceutics 2021, 18(3):1277-1284.
  588. Zhou Y, Flores S, Mansor S, Hornbeck RC, Tu Z, Perlmutter JS, Ances B, Morris JC, Gropler RJ, Benzinger TL: Spatially constrained kinetic modeling with dual reference tissues improves 18 F-flortaucipir PET in studies of Alzheimer disease. European Journal of Nuclear Medicine and Molecular Imaging 2021:1-15.
  589. Zhu P, Wu M, Ma B, Wang S: Application of 18‑fluorodeoxyglucose as an indicator of symptom severity in a rat model of tic disorder following treatment with traditional Chinese medicine. Experimental and Therapeutic Medicine 2021, 21(1):1-1.
  590. Zubair M, Murris SR, Isa K, Onoe H, Koshimizu Y, Kobayashi K, Vanduffel W, Isa T: Divergent whole brain projections from the ventral midbrain in macaques. Cerebral Cortex 2021, 31(6):2913-2931.
  591. Zürcher N, Loggia M, Mullett J, Tseng C, Bhanot A, Richey L, Hightower B, Wu C, Parmar A, Butterfield R: [11C] PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder. Molecular psychiatry 2021, 26(5):1659-1669.